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Given the high cost and emerging ethical and public concerns associated with the use of
animal models, the use of in vitro techniques is gaining considerable attention in research programs
related to CNS drug discovery and development. More specifically, various in vitro cell culture
models for studying and predicting drug transport across the Blood-Brain Barrier (BBB) were
developed as preclinical research tools for neurological drug discovery and development. The main
goal of the present studies has been to improve conventional in vitro methods used in mimicking
the BBB physiology and functions by allowing physiologically complex interactions of the human
BBB cells (astrocytes, pericytes, and Brain Microvessel Endothelial cells or the BMECs) to occur
in vitro. This goal was achieved by carrying out a systematic seeding of layers corresponding to
all the principal cellular components of a human BBB, such that a confluent and continuous layer
of BMECs would form on a basement of human brain astrocytes and pericytes.
Therefore, it was hypothesized that if complex interactions among these BBB cells were
allowed to occur in vitro, then this would lead to an improved multicellular culture model of the
BBB system, showing better paracellular tightening in comparison to the conventional BBB
monoculture models. Results presented in this dissertation indicate that a confluent and continuous
layer of hCMEC/D3 cells (an immortalized BBB cell line) was formed directly on a basal coculture
made of astrocytes and pericytes layers to make a physiological configuration resembling that of
the human BBB in vivo. The resulting direct-contact triculture model was more restrictive to the
permeation of various paracellular markers (mannitol, sucrose, PEG-4000 and inulin) than its
corresponding monoculture of hCMEC/D3 cells.
In order to compare the transcellular absorption between mono- and tri-culture models,
digoxin (an FDA recommended probe substrate for efflux transporters) and elacridar (an FDA
recommended potent inhibitor of efflux transporters) were used to compare efflux activity between
the mono- and tri-culture models. While, a statistically significant effect of elacridar on the
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absorption of digoxin was observed in the hCMEC/D3 monocultures, there was no statistically
significant effect of elacridar on the absorption of digoxin in the triculture model. The observed
difficulty to increase the absorption of digoxin using a potent Pgp inhibitor (elacridar) in the
triculture model is in agreement with previously published research showing that it is difficult to
improve brain drug exposure even when efflux transporters at the human BBB are inhibited. In
addition, the triculture model showed a valid ranking order of transcellular BBB permeants; Lhistidine (a non-Pgp substrate) showed higher apparent permeability, followed by thiamine (a Pgpsubstrate, but essential for brain function), followed by propranolol (a weak Pgp substrate), then
paclitaxel, and the lowest permeability corresponded to verapamil which is a strong Pgp substrate.
The final chapter of this dissertation provides possible strategies on how the triculture
methodology can be further improved and applied in an industrial setting as a screening tool for
studying the effect of pharmaceutical drugs and drug products on the BBB physiology and
functions. Ultimately, it is hoped that the triculture will be useful in the creation of IVIVC models
to predict clinical pharmacokinetic and pharmacodynamic parameters.
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CHAPTE R 1.
JUSTIFICATION FOR THE DEVELOPMENT OF A
LAYERED DIRECT-CONTACT TRICULTURE MODEL OF THE
BLOOD-BRAIN BARRIER

1.1

Summary

Objectives: To explain the BBB-concept and to propose a physiologically representative
methodology for mimicking the BBB-glial unit on a TranswellTM membrane.
Findings: The role of three CNS-barriers (the BBB, the blood-CSF, and the arachnoid barrier) in
limiting neurological drug delivery is described. The BBB-glial unit is considered the most
relevant barrier in neurological drug delivery. Under normal physiological conditions, brain
capillaries (or the BBB) deliver nutrients, energy molecules and other important molecules to the
neurons. However, the BBB is a selective conduit system that allows delivery of certain molecules
such as nutrients to the neurons but prevents neurological drug delivery. Strategies to deliver
neuronal drugs through the BBB are highly needed in order to halt the high attrition rates in CNSdrug development.
Research problem: It is a Herculean task to study drug transport across a BBB-glial unit in vivo.
One of the current approaches to address this challenge involves mimicking the BBB-physiology
on a TranswellTM in order to study BBB-drug transport mechanisms and permeation rates.
However, conventional methods are not optimized to allow the formation of physiologically
relevant cell-cell junctions and vesicular exchange as it occurs between cellular constituents of the
BBB-glial unit in vivo. While it is known that astrocytes, pericytes and endothelial cells of the
BBB-system do exchange cell organelles, mRNAs, ions and small molecules through direct cellcell connections, conventional TranswellTM methods separate astrocytes and pericytes from the
BBB-endothelial cells by plating them on different sides of a thick membranous filter support.
Thus, conventional methods need to be optimized to allow for the formation of direct cell-cell
channels (gap junctions or peg-socket junctions). Cell-cell junctions/channels that form among
BBB cells (i.e., astrocytes, pericytes and BMECs) offer an alternative route through which
neuroactive drugs may circumvent rapid clearance by a circulating brain-CSF in the CNS
compartments.
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A novel methodology for mimicking the BBB on a TranswellTM support:

A novel

methodology in which astrocytes, pericytes, and BMECs are seeded in direct layers on a transwell
membrane would form a more representative model of the BBB in vitro. Chapters 2, 3, & 4
describe the development of a direct-contact triculture model of the human Blood-Brain Barrier.
Variants of the direct-contact triculture model of the BBB are described here in chapter 1.
Keywords: CNS barriers, BBB-glial unit, CNS-drug delivery, neuronal drug delivery, gapjunctions, peg-socket junctions, TranswellTM.

1.2

Introduction
Paul Ehrlich discovered the BBB more than 100 years ago, when he noticed that hydrophilic

dyes injected into blood circulation could not be absorbed into the brain region [Ribatti et al.,
2006]. Since then, much knowledge has been gained about the role of CNS barriers in limiting
drug delivery into brain parenchyma [Pardridge, 2011 & 2016]. The process of CNS-drug
absorption is regulated by a system of CNS-barriers including the BBB, the brain arachnoid
epithelia and the blood-CSF barrier [Pardridge, 2011 & 2016]. A successful strategy for CNS drug
delivery would have to consider a delicate transport system controlled by these three main CNSbarriers [Pardridge, 2011 & 2016].
Even though transport of CNS drugs may occur at all three major CNS barriers, experts
consider the BBB to be the most difficult drug delivery barrier in CNS drug development
[Pardridge, 2011 & 2016]. CNS-drug absorption via epithelial cells of the choroid plexus is much
higher than the absorption through the BBB-microvascular unit [Pardridge, 2011 & 2016].
However, drug delivery through the blood-CSF barrier is not feasible; drug diffusion from CSF
into the brain tissue/neurons is limited due to a rapid clearance by the efflux pumps back into the
blood circulation system [Pardridge, 2011 & 2016].
The arachnoid epithelial barrier may contribute to the absorption of drugs into the CSF
circulating in the brain ventricles [Yasuda et al., 2013]. However, drugs absorbed this way would
still be highly cleared in the same way as drugs absorbed through the blood-CSF barrier. Thus,
more efforts are focused on understanding drug absorption through the BBB-capillaries. A
successful absorption of a CNS-drug/drug delivery system, through the BBB-cell layers, would
increase its concentration levels at neuronal sites. The close association and direct connections
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formed between neurons and cells of the BBB-glial vascular unit makes the BBB a formidable
interface through which a potential CNS-drug would be delivered directly to the neurons while
avoiding CSF dilution and clearance back into blood circulation.
Therefore, a perplexing challenge in CNS drug development is not how to get the drug into the
brain-CSF, but rather, how to deliver CNS-therapeutics through the BBB-cell layers to achieve
effective concentrations at neuronal sites, while avoiding CSF dilution and clearance back into the
blood circulatory system. Preclinical methods for understanding drug absorption through layers of
the BBB-cells would be useful in predicting which CNS-drug candidates/delivery strategies would
work successfully in a clinical setting. A major purpose of the research reported here is to develop
a novel methodology in which a CNS-drug candidate would be exposed to a directly stacked layer
of BBB-cells, in order to predict if it would be well absorbed through the glial vascular unit/the
BBB in vivo.

1.3

Blood-brain barrier glial unit
Brain endothelial microvessels together with the associated pericytes and astrocytes form a

multicellular control unit that regulates molecular trafficking between blood in the lumen of brain
microvessels and the brain parenchyma [Obermeie et al., 2013]. The BBB unit may be regarded
as a smart and complex physiological barrier that uses multiple mechanisms to accomplish
multiple tasks at the interface of brain and blood circulatory system [Pardridge, 2002]. The
principal cellular components of the BBB are the brain microvessel endothelial cells (BMECs),
pericytes and astrocytes [Persidsky et al., 2006]. The BBB-capillary is continuous and completely
covered by a combination of pericytes and astrocytes [Mathiisen et al., 2010]. Together, these cells
form a formidable control unit that protects the CNS environment from peripheral fluctuations
[Weiss et al., 2009].
The large surface area (15-25 m2) of the brain microvasculature/the BBB would be ideal for
CNS-drug absorption; however, most small molecule drugs are not able to cross these capillaries
[Wong, 2013]. Though the BBB plays a neuroprotective role, stopping neurotoxic drugs from
getting into the CNS region, it also prevents most neurotherapeutics from gaining access to the
brain neurons [Pardridge, 2005]. Consequently, many neurological diseases may not be cured,
largely due to the inability of scientists to develop drug delivery systems that would circumvent
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the BBB protective mechanisms [Pardridge, 2005]. Thus, in vitro methods for mimicking specific
BBB-functions are needed for applications in CNS-drug delivery research [Mangas-Sanjuan et al.,
2013].
It is highly important to understand relevant BBB-properties prior to developing methods for
mimicking specific aspects of the BBB-physiology in vitro. It is also improbable that a single cellline based technique would capture all the relevant features of the BBB-system. Different cell lines
may be used to obtain specific information regarding the BBB transport [Morrissey et al., 2012].
For example, the potential for a BBB drug-drug interaction due to Pgp efflux activity has been
traditionally evaluated in the MDCKII-MDR1 cell line that overexpresses Pgp. The potential for
a drug to cross the BBB using an uptake transporter may employ a cell line overexpressing the
transporter of interest, e.g., KCL22 cell line overexpressing OCT1 would be used to predict the
potential for a novel CNS-drug to be delivered through an OCT1 carrier [Morrissey et al., 2012].
It should be noted that most BBB-transport properties are evaluated using animal cell lines.
Such cell lines may present significant species differences and hence undermine their predictive
capability [Deo et al, 2013]. Therefore, there is a need to develop more human cell lines for
application in CNS- drug permeability and transporter assays. Although an immortalized human
cell line, the hCMEC/D3, is gaining popular application in BBB research, additional human cell
lines representing specific BBB states may be more informative in specific CNS-drug delivery
studies. For example, the hCMEC/D3 cell line would perhaps be relevant in studies related to a
cancerous BBB since it is transfected with oncogenes to allow it to proliferate over many passages.
However, it may not be useful for application in studies related to a healthy BBB.

1.4

BBB transport properties
The BBB is a multipurpose physiological barrier, allowing the uptake of select molecules from

blood circulating in the lumen of brain microvessels, but also restricting the entry of potential
therapeutic molecules for neurological diseases [Takeshita et al., 2015]. The ability for the BBB
to carry out such multiple functions is due to its unique physiological properties involving complex
interactions between the BBB-endothelia, BBB-pericytes, BBB-astrocytes and the extracellular
matrix secreted by all these BBB-cells. Furthermore, the BBB functions concertedly with the CSF
circulating in the brain ventricles in order to clear drugs (or metabolites) that enter into brain
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ventricles through the blood-CSF barrier further limiting CNS-drug diffusion and distribution into
the brain parenchyma [Wolak and Thorne, 2013]. A summary of key structural and physiological
properties used by the BBB-system to regulate movement of molecules in and out of cerebral
region is provided in the next subsections.
1.4.1 Cell-cell junctions
Cell junctions at the BBB-cells limit free diffusion of most large and small molecules (assuming
no carrier-mediated transport) in and out of the brain-CSF [Stamatovic et al., 2008]. The BBB cellcell junctions are manifested in different forms including junctional complexes, peg-socket
junctions, gap junctions and adhesion plaques [Haddad-Tóvolli et al., 2017]. These types of cell
junctions may be expressed between the same kind of cells, e.g., between two endothelial cells, or
between different kinds of cells, e.g., between a BBB-endothelium and a pericyte [Limmer et al.,
2014].
An in vitro methodology that allows for optimal contacts among cellular constituents of the
BBB-glial unit would allow pharmaceutical scientists to understand the role of all the BBB cellcell junctions, and not only the endothelial tight junctions, in CNS-drug disposition. Specific cellcell junctions at the BBB glial vascular unit are described briefly in the next subsections.
1.4.1.1 Junctional protein complexes
The BBB-endothelium expresses two main categories of junctional proteins, namely the tight
and the adherent junctions [Tietz & Engelhard, 2015]. Tight junctions are formed by the
overlapping membrane-protein loops between two adjacent BBB-endothelia [Tietz & Engelhard,
2015]. Transmembrane proteins that form tight junctions include the occludin, various isoforms of
claudins, and JAMs [Tietz & Engelhard, 2015]. Details on the molecular biology of junctional
protein complexes is beyond the scope of this study (detailed information can be found in current
neuropharmacology, 2008, vol 6 No.3.).
In summary, a complex network involving adherent junctional complexes such as VEcadherin, and the cytoplasmic junctions such as ZO-1, 2, and 3, further control the integrity of
BBB-endothelial tight junctions [Tietz and Engelhard, 2015]. A high expression of the
aforementioned protein complexes in the BBB cell models correlates with a more restricted
paracellular permeation indicated by a low paracellular permeability or high TEER values [Helms
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et al., 2010]. A major endeavor in the development of BBB-cell models has been to obtain a highly
restrictive cell line manifesting high TEER values in excess of 1000 Ω-cm2 [Thomson et al., 2015].
1.4.1.2 Peg & socket junctions
The BBB-endothelium interacts with pericytes by forming membrane interdigitations known
as peg-socket junctions (pericytes form pegs and endothelial cells form sockets) [Armulik et al.,
2005]. Adherent and gap junctions further stabilize peg-socket junctions and prevent membrane
mixing of pericytes and BBB-endothelia [Winkler et al., 2011]. In addition, peg-socket junctions
are stabilized by membrane integrins that anchor pericytes and endothelial cells in a thick
extracellular matrix [Winkler et al., 2011].
Direct contacts formed between pericytes and endothelial cells are prerequisites for various
signaling events that lead to the control of many properties of the BBB-endothelia [Winkler et al.,
2011]. Peg-socket junctions may play an important role in regulating the permeation of
neurological drugs or CNS-drug delivery systems. An in vitro method that allows the formation of
peg-socket junctions between BBB-cell models could be useful in cases where a CNS-drug or drug
delivery system is designed to use peg-socket junctions as a delivery channel to reach cerebral
neurons.
1.4.1.3 Gap junctions
There exist direct connections between all the BBB cells formed through cell-cell contacts
known as gap junctions [Brink et al., 2012]. Gap junctions consist of intercellular hemi channels
that connect two adjacent cells to allow the transfer of small molecules, ions or signaling molecules
between cells [Zong et al., 2016]. Given that free drug molecules circulating in the brain CSF can
hardly diffuse in the brain tissue to reach neurons, the alternative passage of neurological drugs
from the BBB-endothelium to the neurons may be achieved through a series of channeling
junctions that connect the BBB-endothelium to the astrocytes and pericytes and eventually to the
neurons in the brain parenchyma. In addition, a neurological drug delivered via gap junctions may
avoid dilution and clearance by the CSF circulating through brain ventricles or extracellular spaces
[Brink et al., 2012]
There is a gap-junctional protein, connexin-43, which connects the BBB-endothelium to the
astrocytes, and the astrocytes to a neuron [De Bock et al., 2014]. Thus, it is possible for a
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therapeutic molecule/drug delivery system to escape brain-CSF dilution or clearance by traveling
through an intracellular pathway established through gap junctions in order to reach the
intracellular lumen of a diseased neuron. The interactions of BBB-cells through gap junctions may
be achieved by mimicking their physiological configuration in vitro whereby layers of astrocytes
and other BBB-cell models are seeded directly onto one another. The purpose of this research is
to propose a novel in vitro methodology that would allow the formation of gap junctions among
BBB endothelia, pericytes and astrocytes.
1.4.2 Cell transmigration
Under certain pathological conditions such as Multiple Sclerosis, the BBB allows leukocytes
to cross from CNS-periphery into the brain parenchyma [Genaro et al., 2014]. Leukocyte
trafficking across the BBB is believed to involve four steps: tethering and rolling; activation;
adhesion; and diapedesis [Lopes-Pinheiro et al., 2016]. In the first step (attachment on the
endothelial), a leukocyte adheres on the BBB-endothelia through a biochemical interaction
involving carbohydrate ligands expressed on leukocytes, and also selectins and chemokines
expressed on the BBB-endothelial cells [Lopes-Pinheiro et al., 2016]. A leukocyte bound on the
BBB-endothelial wall triggers an intracellular signaling cascade that causes endothelial junctions
to open for a leukocyte to pass through the BBB-glial unit. Once a leukocyte has migrated, the
BBB-junctions close again [Lopes-Pinheiro et al., 2016].
There is interest in understanding mechanisms by which cells undergo diapedesis at the BBB;
in the future, CNS-drugs may be delivered across the BBB to diseased neurons via mechanisms
involving diapedesis [Ali IU et al., 2015]. In vitro cell culture methods for mimicking the BBBglial unit may be applied in understanding cell transmigration across the BBB [Sreekanthreddy P
et al., 2016].
1.4.3 Vesicular transport
Drugs of abuse such as METH may induce/ enhance vesicular transport at the BBB and hence
compromise the neuroprotective function of the BBB [Martins et al., 2013]. Vesicular transport of
macromolecules such as insulin or transferrin at the BBB may involve transcytosis or endocytosis
[Jones and Shusta, 2007]. Disease causing agents such as viruses or bacteria may infiltrate through
the BBB using phagocytes or leukocytes as Trojan horses [Dando et al., 2014]. Thus, the BBB-

8
system can be a pharmacological target for halting the entry of microbial or viral agents into the
brain parenchyma.
Although macromolecules such as insulin or transferrin cross the BBB using transcytosis,
efforts to deliver promising neurotherapeutics via transcytosis have not yielded positive results
[Mager et al, 2017]. There is a need to understand the molecular basis of transcytosis in order to
develop successful CNS-drug delivery strategies that exploit receptor mediated transcytosis
[Mager et al, 2017]. Although research in the molecular basis of drug transcytosis is still in its
nascent stage, it may require the availability of in vitro BBB models that would capture all the
relevant aspects of transcytosis at the BBB. Specifically, in vitro BBB models containing BMECs,
pericytes, and astrocytes in direct configuration would be more informative since pericytes are
known to control transcytosis at the BBB [Dohgu and Banks, 2013]. Astrocytes are also known to
be mediators in the transcytosis of nutrients across the BBB and to deliver them to a neuronal
environment [Seneff et al., 2011].
Therefore, an in vitro BBB model containing BMECs, pericytes and astrocytes would be the
most physiologically relevant for application in studies related to nutrient/drug transcytosis across
the BBB-system.
1.4.4 Membrane transporters
Drug transporters at the human BBB may affect CNS-drug concentration levels in the brain
CSF and brain cells. The membrane bound drug transporters found at the BBB fall into two broad
categories: uptake and efflux transporters [Uchida et al, 2011]. Therefore, precautions have to be
taken in preclinical drug development to ensure that a novel CNS or non-CNS drug would not be
a substrate for select BBB-regulatory transporters [Zhang et al., 2006].
If a novel CNS-drug candidate is a substrate for key uptake transporters (OAT3 or OCT2), or
key efflux transporters (Pgp or BCRP), then it may lead to clinical drug-drug interactions and/or
neurotoxicity [Zhang et al., 2006]. In some cases, a novel CNS-drug candidate may interact with
a peripheral drug such as digoxin (a substrate for OATP and Pgp) at the efflux pumps of the BBBcells to increase their concentration in the brain parenchyma and hence cause neurotoxicity [Mayer
et al., 1996; Taska et al., 2017]. Thus, in vitro prediction of drug-drug interaction and potential
neurotoxicity is of paramount significance in preclinical drug development.
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Efflux pumps at the BBB are expressed at the endothelial and astroglial levels [Decleves et
al., 2000]. However, efflux assays for potential CNS-drug candidates are rarely performed in the
astroglial cell cultures, perhaps because efflux assays in the BBB-endothelial cells would be
sufficient to predict the potential for drug-drug interactions. However, if a comparison in the
fraction of CNS-drug absorbed through the BBB-layers is required, then it may be relevant to use
in vitro methods that contain not only the BBB-endothelia but also astrocytes and pericytes.
1.4.5 Lipophilic diffusion
Cell membranes at the BBB allow passive diffusion of certain lipophilic drugs. The optimal
molecular properties for lipophilic CNS drugs include a log P value ranging from 1.5 – 2.7; a
molecular weight ranging between 400 – 600Da; the number of (O+N) ≤ 5; a polar surface area
between 60Å2 - 90Å2; and a positive charge in the pH range between 7 and 8 [Pajouhesh and Lenz,
2005]. There are additional non-BBB factors that may hinder neuronal bioavailability. For
example, a lipophilic drug circulating in the lumen of a brain capillary may bind to red-blood cells,
or serum proteins and may become unavailable for BBB permeation [Tanaka and Mizojir et al.,
1999].
In addition, the fraction of drug molecules not bound to the serum proteins may diffuse
through the cell membranes to interact with membrane bound proteins that would, in turn, reduce
their effective permeability through the BBB-cells [Mateus et al., 2013]. Lipophilic drugs that bind
membrane-bound proteins may be effluxed back into the lumen of a blood capillary, or, may
simply accumulate in the BBB-cell membranes when efflux pumps are inhibited [Mankhetkorn
and Garnier-Suillero, 1998].
Lipophilic drugs that escape membrane-bound proteins may bind to cytoplasmic proteins or
to metabolic enzymes that may further reduce their bioavailability across the cell membranes
[Molinari et al., 2002; Yamagishi et al., 2013; Mateus et al., 2017]. However, intracellular protein
binding may also assist in cytoplasmic trafficking of CNS-drugs/nutrients from the apical side of
a cell membrane to the basolateral side towards neurons [McArthur et al., 1999].
A lipophilic drug molecule that has escaped protein binding at various levels may still be
hindered from diffusing freely through brain interstitial fluids to get to the target neuronal receptors
due to non-specific tissue binding [Maure et al., 2005]. Thus, lipophilic drug delivery through cell
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membranes of the BBB-glial unit would be highly limited by non-specific protein binding at
various locations in and out of the cell milieu. A physiologically representative in vitro
methodology for estimating and comparing the free fraction of a lipophilic drug escaping most of
the BBB protective mechanisms may help in the selection of drugs with optimal physico-chemical
properties for lipophilic diffusion.

1.5

Mimicking the BBB function in a TranswellTM
As described in the preceding sections, the BBB is a smart, multicellular barrier at the interface

between blood and brain parenchyma. The BBB accomplishes its neuroprotective role through
complex cellular and biochemical networks that may be complicated to mimic using simple cell
culture models in TranswellTM chambers. It should be noted that the BBB problem is even more
complex as its physiology is very dynamic, manifesting different physiological states under
different pathological conditions [Guérin et al., 2001]. However, a good starting point in
mimicking the BBB in vitro would be to form a multicellular culture of the principal cellular
constituents of the BBB in a configuration resembling that of the BBB in vivo.
Conventional methods for modeling the BBB on a TranswellTM may not allow for the formation
of optimal contacts and biochemical networks that exist at the BBB-system in vivo (see Figure
1.1). The problem is that usually, BMECs are seeded on the apical surface of a TranswellTM
membrane while the astrocytes and pericytes are seeded on the basolateral surfaces, separated from
endothelial cells by a physical wall of the filter support of varying thickness (120μm, 50μm, and
10μm thickness; see Figure 1.2 for comparisons with the cell thickness). In such a TranswellTM
setting, pericytes and astrocytes may not be able to form optimal junctions with endothelial cells,
and the diffusional or transport pathway of a drug or drug delivery system may not be elucidated
in vitro, if the BBB configuration is misrepresented in in vitro transport studies.
For example, a novel drug or drug delivery system in vivo may be exchanged from endothelial
cells into pericytes and astrocytes, then to the neurons by mechanisms that involve either gap
junctions or peg-socket junctions, or vesicular exchange, or uptake transporters in series. Of equal
importance would be drug clearance from brain CSF. A novel drug or drug delivery system
delivered in the brain parenchyma through non-BBB routes, such as nasal or direct injection in the
spinal cord may be conversely cleared into the blood circulatory system by a combination of
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transport mechanisms that exist between the BBB-endothelia, astrocytes and pericytes [Deane et
al., 2009]. In vitro cell culture methods may be equally useful in investigating clearance of
molecules from brain parenchyma into the lumen of brain capillaries. More specifically, the role
of astrocytes and pericytes in cerebral drug clearance could be investigated using a directly layered
multicellular model of the BBB that closely mimics the actual BBB physiology and function in
vivo.
Therefore, cell culture methods used in mimicking the BBB function could be more
informative if the BBB-endothelia were free to form direct interactions/connections with
astrocytes and pericytes by seeding direct layers of these BBB cells on the same side of a
TranswellTM chamber (apical or basolateral). The new approach proposed in here would allow the
BBB-endothelia, pericytes and astrocytes to interact freely on either the apical or the basolateral
surface of a TranswellTM membrane. This approach would allow for more spatial freedom to add
other cellular components that are closely associated with the human BBB (i.e., neurons and
microglia). The proposed direct-contact methodology could be suitable for application in studies
related to CNS-drug delivery strategies and mechanisms.

1.6
I.

II.
III.

Specific research aims
To develop a direct-contact method for mimicking BBB-physiology on a TranswellTM
support using the methodology described in Figure 1.3. The proposed method is expected
to allow direct contacts (cell-cell junctions) between BBB-endothelia, pericytes and
astrocytes to allow free cell-cell interactions similar to the contacts formed between BBB
cells at the glial-vascular unit in vivo.
To compare cross-sectional configuration of a directly layered tricellular culture model of
the human BBB to that of the human BBB in vivo
To evaluate potential application of a direct triculture model of the BBB glial vascular unit
in predicting potential clinical drug-drug interactions using digoxin as a Pgp probe
substrate and elacridar as a potent non-competitive inhibitor of efflux transporters
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P
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Figure 1.1. A neuroprotective BBB. The bright green arrow shows a neuron (N), the light blue
arrow shows an astrocyte (A), the black arrow shows a pericytes (P) and the purple arrow shows
a BBB-endothelium. Note that for a neuronal drug delivery to be attained, a drug molecule would
have to be transported past the BBB-endothelium, the extracellular matrix, and pericytes or
astrocytes. Cell-cell junctions (molecular channels) that connect neurons, astrocytes, pericytes
and the BBB-endothelium may provide an alternative transport pathway to circumvent tight
junctions, extracellular enzymes, and CFS clearance in neuronal drug delivery. An in vitromulticellular model of the BBB that allows for unlimited and direct interactions between the
cellular constituents of the BBB-glial unit would be useful in preclinical CNS-drug delivery
studies.
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EC
PC
AC
Figure 1.2. Lack of optimal cell-cell interactions in the conventional methodology when
modeling the BBB-glial unit on a TranswellTM support. EC stands for Endothelial Cells, PC for
pericytes, and AC for astrocytes. A thick membrane filter support limits the formation of cellcell junctions between ECs and PCs. In addition, ACs are seeded at the bottom surface where
they are largely separated from ECs and PCs. Therefore, optimal cell-cell channels such as gap
junctions, peg-socket junctions may not be formed between ACs, PCs and ECs. Figure 1.2 was
reproduced with permission from Elsevier [Cerruti et al. 2011].
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(A)

Blood side

Brain side

(B)

Brain side

Blood side

(C)

Blood side

Brain side

Figure 1.3. A direct-contact triculture methodology for mimicking the BBB-glial unit on a
TranswellTM support. Configuration (A) involves seeding the triculture on the apical surface,
(B) is an inversed configuration of (A), and (C) is configuration (A) seeded on the
basolateral surface of a transwell membrane. The proposed methodology leads to a spatial
arrangement that would allow for additional cellular components of the neurovascular unit
to be added in the model.
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1.7

Concluding remarks
The role of CNS-barriers is highly diversified. CNS barriers have multiple functions including

neuroprotection, molecular delivery of nutrients to the neurons, clearance of neurotoxic
compounds and metabolites. A distinction between CNS-drug delivery and neuronal drug delivery
ought to be clarified before justifying the need to develop a directly layered triculture model of the
human BBB. While many small and large molecules may gain access into CNS-ventricles through
the blood-CSF barrier, or, through direct injection into the spinal cord, the circulating CSF would
rapidly clear drugs delivered through these non-BBB routes via paravenous drainage pathway and
hence limit their bioavailability to the target diseased neurons [Tachikawa et al., 2008; Iliff et al.,
2012].
Of all the three CNS-barriers/conduits, the BBB location and distribution in the brain
parenchyma make it a better conduit for optimal neuronal drug delivery. The distance between a
BBB-capillary and a brain neuron (8-20 μm) is optimized to allow a fast transfer of select nutrients
and oxygen from the lumen of a BBB-capillary to the neurons [Spencer and Verma, 2007]. It is
approximated that each neuron in the brain parenchyma is associated with at least one BBB-glial
unit [Spencer and Verma, 2007]. Thus, a neuronal drug delivered through the BBB would escape
rapid clearance by the interstitial fluid flow and would be well distributed in the cerebral region
where target diseased neurons are extremely difficult for most therapeutic molecules to get access
[Spencer and Verma, 2007]. The main challenge in neuronal drug delivery is not how to
circumvent the BBB to gain access to various CNS compartments but rather how to use the BBB
as a conduit for delivering promising neurological drugs.
Neuronal drug delivery through the BBB glial-vascular system could be investigated during
preclinical stages by using the proposed multicellular culture models that closely mimic the BBB
physiology and function in an in vitro setting. Conventional cell culture methods for mimicking
the BBB function/physiology are not optimized to allow for the formation of intracellular channels
(e.g., gap junctions and peg-socket junctions that form between BBB-endothelia and astrocytes or
pericytes) that may act as additional conduits for trafficking drug molecules from the
apical/lumenal side of the BBB to the basolateral/ablumenal side. A novel direct-contact
methodology that involve direct layers of BBB-endothelia, pericytes and astrocytes would better
mimic the BBB physiology and function than conventional methods that involve separation of the
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three principal cellular components of the BBB glial vascular system. A detailed description on
the development and testing of a direct-contact triculture model of a human BBB as a potential
CNS-drug research tool is given in the proceeding chapters.
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CHAPTER 2.
IMPROVED PARACELLULAR TIGHTNESS IN THE
DIRECT-CONTACT TRICULTURE MODEL OF THE BLOOD-BRAIN
BARRIER

2.1

Summary

Background: The human blood-brain barrier (BBB) has traditionally been mimicked in
preclinical drug development using cell-culture methods prepared from animal or human cells.
However, many of the conventional cell-culture methods have not been optimized to allow direct
cell-cell contacts or proximal associations between human brain astrocytes and/or pericytes with
brain microvessel endothelial cells (BMECs) to form a physiological configuration similar to that
of the human BBB in vivo. A novel cell-culture method in which human primary brain astrocytes,
pericytes and BMECs are cultured in direct contact on the apical surface of a TranswellTM to form
a direct –contact triculture model of a human BBB is described in this chapter. The contribution
of astrocytes and pericytes in the resulting layered triculture model is delineated in order to
understand the role of these non-endothelial cells in reinforcing the paracellular tightness of the
BBB system. The permeability values of various established paracellular marker molecules are
used to compare paracellular tightness in the mono-, co- and tri-cultures that are used for partial
or full mimicking of the BBB-system.
Methods: TEER (Trans-Endothelial Electrical Resistance) values were used as a guide to establish
when stable, optimal tightening of paracellular permeation route occurs post culturing of the
hCMEC/D3 cells on a pre-attached coculture of pericytes on astrocytes. Upon reaching stable
TEER values, permeability coefficients of sucrose and mannitol (smaller paracellular marker
compounds), were then obtained from monocultures of hCMEC/D3 cells, cocultures of
hCMEC/D3 cells with astrocytes or pericytes, and tricultures containing layers of all the three
types of BBB cells. In addition, permeability coefficients of mannitol through cocultures of
pericytes that were directly seed onto pre-attached astrocytes were determined and compared to
the values obtained under the hCMEC/D3 monoculture and tricultures. Evaluation of this novel
triculture model of the BBB followed standard methodology needed to characterize new cell
culture methods for mimicking the BBB in vitro.
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Results: A co-culture of astrocytes and pericytes, directly over-layered, showed a normalized
TEER value of 43±9 Ω-cm2 when both the astrocytes and pericytes layers were seeded at a density
of 4 x 104 cells/cm2. A direct seeding of hCMEC/D3 cells at 8 x 104 cells/cm2 on the basal
coculture of astrocytes and pericytes led to a 46% gain in normalized TEER-values with a
maximum value observed in the resulting triculture at 81±6 Ω-cm2. The permeability co-efficient
of mannitol was similar between cocultures of pericytes grown on a layer of astrocytes versus
monocultures of hCMEC/D3 cells, i.e., (6.9±0.16) x 10-5 cm/s, across the cocultures, and (6.3±0.34)
x 10-5 cm/s in the monoculture of hCMEC/D3 cells. The tricultures developed by seeding
hCMEC/D3 cells directly on a basal coculture of astrocytes and pericytes was more restrictive to
the permeation of smaller (mannitol and sucrose) and larger paracellular permeants (PEG-4000
and inulin-5000) when compared to the monoculture of hCMEC/D3 cells alone.
Conclusions: A direct co-culture of astrocytes and pericytes exhibited a resistance to the flux of
mannitol, a small paracellular permeant, in a similar magnitude to that experienced by mannitol
through a monoculture of hCMEC/D3 cells. When hCMEC/D3 cells were seeded directly onto a
layered coculture of astrocytes and pericytes, the resulting triculture became a system of barriers
that help provide a more physiologically relevant configuration in support of the hCMEC/D3
barrier cultured at the top section of a BBB triculture model. The Permeability coefficients of
various paracellular permeants indicated that the triculture model of a human BBB is significantly
tighter than the corresponding monoculture model containing only the hCMEC/D3 cells. Thus, a
direct-contact in vitro triculture methodology described in this chapter may better mimic
paracellular barrier function of a human BBB than a monoculture methodology, which is only a
partial representation of the BBB system.
Key words: Blood-Brain Barrier, tight junctions, Trans-Endothelial Electrical Resistance (TEER),
and paracellular permeation
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2.2

Introduction
The transport phenomena of small or large molecules, in and out of the brain parenchyma, is

controlled by the Blood-Brain Barrier [McAllister et al., 2001; Pardridge, 2005]. The human BBB
is a multi-cellular barrier consisting of an endothelium capillary surrounded by pericytes and
astrocytes that are widely believed to be very important in mass transfer resistance to most
xenobiotics [Zlokovic BV, 2008, see Figure 2.1].

Figure 2.1. BBB-glial vascular unit. AF stands for Astrocytic-Foot process, E stands for endothelial
cell, and P stands for pericyte. Note that blood in inside the endothelial capillary lumen does not
cross the paracellular space of the endothelial cells. The junctional space of the endothelial cells
(blue region) is filled with tight junctions that restrict free passage of cells, serum proteins and
molecules circulating in the capillary lumen from accessing the brain parenchyma.

The direct interactions between brain endothelial capillaries and the supporting pericytes and
astrocytes have been implicated in the regulation of properties that are unique to the BBB. For
example, pericytes form direct connections with endothelial cells through peg socket-like junctions
or gap junctions that allow for the transfer of small molecules or ions from endothelium into the

24
brain parenchyma through direct physical connections that they form with other BBB cells
[Armulik et al., 2011; Kloc et al., 2015]. While gap junctions are commonly formed between cells
of the BBB system, conventional methodologies for mimicking the BBB function in vitro are not
optimized to allow direct physical configuration between astrocytes, pericytes and the BMECs
[Trosko et al., 2000, Dere and Zlomuzica, 2012].
While astrocytes do not form continuous physical connections with the BBB-endothelium,
they form a close association for paracrine signaling with BMECs and pericytes in regions of the
brain capillaries that lack direct physical contacts with astrocytes [Abbott, 2002]. For example, it
is well known that astrocytes are involved in paracrine signaling with pericytes and the BBBendothelium in order to control the passage of substances from the lumen of blood capillaries into
the brain parenchyma [Cleaver & Melton, 2003; Argaw et al., 2012; Prasad and Cucullo, 2013;
Shindo et al., 2016]. Conventional in vitro methods employed in mimicking the human BBB lack
the optimal configuration to allow such close interactions between astrocytes, pericytes and
endothelial cells [Ye et al., 2015]. Therefore, a more physiologically relevant method for
mimicking the BBB-physiology is warranted for applications in pharmaceutical drug discovery
and development research [Booth et al., 2012; Wang et al., 2013; He et al., 2014; Wang et al.,
2017].
While some of the recent methods reported in the literature involved plating BMECs directly
on a culture of astrocytes or pericytes, currently no TranswellTM method has been reported in
which astrocytes, pericytes and BMECs are all layered directly on the same side of a filter
support [Sreekanthreddy et al., 2016; Herland et al., 2016]. Instead, methodologies in which
BMECs are cultured on the apical surface of a TranswellTM chamber and astrocytes or pericytes
seeded on the basolateral or bottom surface of a TranswellTM membrane have gained popularity in
BBB research. In fact, BBB co-culture models where either pericytes or astrocytes are cultured at
the basolateral or bottom surface of a TranswellTM chamber are prevalent in BBB research, even
though they form a partial representation of the BBB cells. However, the lack of optimal directcontacts (as observed in vivo), and the laborious efforts that would be needed to establish such a
triculture configuration may render indirect approach more difficult for larger scale applications
in preclinical neurotherapeutic screening. Thus, a novel methodology described in this chapter is
an attempt to improve previous methodologies for mimicking the BBB in vitro, including a
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recently published direct contact co-culture method from our laboratory (see work done by
Kulczar et al., 2017).
There are three key steps involved in developing a direct triculture methodology. First, a
monoculture of primary human brain astrocytes is seeded on the apical surface of a filter support
of a TranswellTM to grow and spread on the surface for two days. Pericytes are then seeded (layered)
directly on a pre-formed lawn culture of astrocytes to grow and establish connections with
astrocytes for two additional days. In a third step, a layer of human BMECs is grown on top of
the astrocytes-pericytes co-culture to form a representation of the human BBB configuration in
vitro. In the present study, restrictive properties of the resulting triculture model are compared to
the cocultures containing hCMEC/D3 cells with pericytes/astrocytes or monocultures containing
just the hCMEC/D3 cells alone (see details in Figure 2.2).
The fact that astrocytes surround most CNS-barriers such as the BBB-capillary, the arachnoid
membranes and meningeal tissue, suggests that they may play an important role in limiting free
permeation of molecules across the BBB towards the brain parenchyma [Sofroniew et al., 2015].
For example astrocytes exhibit a protective mechanism that limits the entry of toxic substances
into the brain parenchyma when CNS-barriers breakdown [Sofroniew and Vinters, 2010]. Thus,
a direct inclusion of astrocytes in the cell culture methods for mimicking CNS-barriers may form
a more physiologically representative model for studying the role of astrocytes in neuroprotection
or neuro-inflammation.
Even though pericytes are not present at all major CNS-barriers, their localization between
astrocytes and the BBB-endothelial wall suggests that they may support BBB-endothelium and/or
the BBB-astrocytes in regulating molecular trafficking at the BBB [Bonkowski et al., 2011; Bai et
al., 2015]. Therefore, the combined role of astrocytes and pericytes in reinforcing the endothelial
barrier function at the BBB is examined in this chapter. It is worth noting that numerous studies
reported an increase in the functional expression of tight junctional proteins in the BBB-cell
models when they were cocultured indirectly with astrocytes or pericytes [Li et al., 2010; Thomsen
et al., 2015; Appelt-Menzel et al., 2017]. The role of astrocytes and pericytes in minimizing
paracellular permeation across a direct-contact triculture model of the BBB may therefore be due
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to upregulation of tight junctions in the BBB cell models such as the hCMEC/D3 used in the
present study.

= astrocyte

= pericyte

= hCMEC/D3 cell

= porous membrane of a TranswellTM
Figure 2.2. BBB-culture models employed in the study: (1) is the hCMEC/D3 monoculture
representing a section of the BBB-glial vascular unit (2), the hCMEC/D3 co-culture with
pericytes; a partial representation of the BBB-glial vascular unit and (3) the hCMEC/D3triculture, which fully mimics the BBB-glial unit as it contains all physiologically relevant
cell layers formed by endothelial, pericytes and astrocytes.

2.3

Hypothesis
Astrocytes and pericytes, together, form a distinct barrier to the permeation of small ions or

molecules in an in vitro BBB triculture model; inclusion of astrocytes and pericytes with the
hCMEC/D3 cells in a direct-contact triculture model of the BBB would lead to enhanced
resistance to the paracellular permeation of hydrophilic molecules.

2.4

Test Parameters
Two types of parameters were used to compare paracellular permeability in the direct-contact

triculture model of the BBB to the paracellular permeability in the mono- or direct-contact coculture models. Two kinds of paracellular permeation were examined; the first kind involved the
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permeability of ion fluxes (Trans-Endothelial Electrical Resistance, TEER), and the second
involved the permeability of hydrophilic molecular permeants that rely on the paracellular
diffusion to cross the layered cultures of BBB cells (astrocytes, pericytes, and BMECs). These
parameters are described in detail in the following sub-sections.
2.4.1 Trans-Endothelial Electrical Resistance (TEER)
There are numerous commercial ohmmeters for use in evaluating the tightness/leakiness of
BBB cell culture models; the Evom2 ohmmeter is one of the most commonly used system to
measure TEER values in cell-cultures [Srinivasan et al., 2015]. For this study, a sharp increase in
TEER values served as a good indicator in the paracellular tightening of BBB-culture models.
However, many factors may affect the reproducibility of TEER values, especially when using
conventional human BBB-cell models [Srinivasan et al., 2015]. Therefore, numerous precautions
should be taken when determining TEER values. First, it is advisable to take TEER measurements
at constant temperature, preferably at 37˚ C [Matter and Balda, 2003]. Otherwise, cell-cultures
should be equilibrated at room temperature for a period of 20 minutes to avoid temperature
fluctuations when TEER values are recorded. TEER-values at 37˚C may then be predicted from
TEER values obtained at room temperature using Blume’s equations [Blume et al., 2010].
Secondly, it is important to use cells at similar passage numbers, preferably low passage
numbers as TEER values start to become highly variable if high cell passage numbers are used in
flux studies [Briske-Anderson et al., 1997]. Thirdly, it is recommended to use same media-buffers
when TEER values are measured; different media buffers have different solute compositions and
may therefore have different electrical properties that would lead to variations in TEER
measurements [Ferruzza et al., 2012]. Therefore, caution needs to be taken when using TEER
values as a guide to inform the analyst when a paracellular tightening occurs in cell culture models
of the BBB system. It is prudent to validate the observed paracellular tightening with permeability
coefficients of small hydrophilic molecules such as sucrose and mannitol.
2.4.2 Permeability coefficients
Small hydrophilic drugs such as cisplatin may diffuse across the BBB through paracellular
tight junctions to cause neurotoxicity [Minami et al., 1996]. It is therefore important to gain insight
on the paracellular tightness of a cell-culture model of the BBB before its application in predicting
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potential neurotoxicity associated with paracellular permeants through cell junctions of the BBB
system. Characterization of paracellular tightness associated with a given BBB-cell culture model
may be estimated using permeability coefficients of small hydrophilic molecule whose molecular
size is similar to that of a typical non-CNS drug like atenolol [McAinsh et al., 1990]. Therefore,
permeability coefficients of small paracellular permeants such as sucrose and mannitol are useful
in probing properties of tight junctions in BBB-cell culture models [Preston et al., 1995; Miah et
al., 2017].
Several precautions ought to be taken when performing paracellular permeability assay. First,
it is important to use media buffers that provide a physiologically representative pH; this would be
a pH of 7.3 for the BBB [Youdim et al., 2003]. Second, the effects of unstirred water layer on the
diffusion of a paracellular permeant should be minimized by using a rocking stage set between 25
to 150 rpms [Youdim et al., 2003]. Third, mass balance should be above 90% at the end of a
paracellular permeability assay to ensure minimal retention of the paracellular marker compound
by the cells [Youdim et al., 2003].

2.5

Materials and methods

2.5.1 Cells and cell growth materials
The hCMEC/D3, human cerebral astrocytes, and the human brain vascular pericytes were
utilized in the development and comparison of a directly layered hCMEC/D3 triculture to the
hCMEC/D3 monocultures and the hCMEC/D3 cocultures with astrocytes or pericytes. The
hCMEC/D3 cell line was donated from Dr. Pierre-Olivier Couraud (Institut Cochin, Paris-France),
human cerebral astrocytes were purchased from ScienceCell (Catalog # 1800), and the human
brain vascular pericytes from ScienceCell as well (Catalog # 1200). The use of hCMEC/D3 cells
is recommended between passage numbers 30 and 40; the hCMEC/D3 are known not differentiate
at this passage interval [Hatherell et Al., 2011]. Therefore, the hCMEC/D3 cells used in the present
study were between passage 33 and 40.
The hCMEC/D3 cells, cultured in collagen-coated T-75 flasks, were grown in EBM-2 media
supplied from Lonza (Catalog # CC 3156 or 19860) and supplemented with 2% fetal bovine serum,
0.03% VEGF, 0.01% hydrocortisone, 5ug/L bFGF, 10 mM HEPES, and 1% penicillin-
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streptomycin.

The hCMEC/D3 culture flasks were kept in a sterile incubator set at 95%

atmospheric air, 5% CO2, and at 37˚C. Primary astrocytes utilized in the study were at passage
numbers between 5 and 10. All astrocytes monocultures were cultivated in Poly-L-Lysine-coated
T-75 flasks, and grown in astrocytes media supplemented with 5mL P/S, 10 mL FBS, and 5mL
AGS solutions, supplied from ScienceCell, per 500mL bottle of astrocyte media. Similarly, the
HBVP (at passage number between 4 and 10 were cultivated in T-75 flasks. Pericytes media were
supplemented with solutions supplied from ScienceCell as follows: 5mL P/S, 10mL FBS, and 5mL
PGS per 500mL of pericytes media. T-75 flasks containing cultures of pericytes or astrocytes
were kept inside a sterile incubator at 95% atmospheric air, 5% CO2, and at 37˚C for the cells to
grow. Each cell type was passaged upon reaching confluency.
2.5.2 Cell seeding
Cell plating densities were first determined in the triculture using various iterations in the
seeding density ratios between astrocytes, pericytes, and the hCMEC/D3 cells. Seeding density
ratios analyzed were [(5 x 103A): (5 x 103P): (1 x 105E)]/cm2, [(1 x104A): (1 x 104P): (1 x
105E)]/cm2, [(4 x 104A): (4 x 104P): (1 x 105E)]/cm2, [(5 x 104A): (5 x 104P): (1 x 10 5E)]/cm2, [(5
x 104A): (5 x 104P): (8 x 104E)]/cm2, [(1 x 104A): (1 x 104P): (1 x 105E)]/cm2, [(4 x 104A): (4 x
104P): (8 x 104E)]/cm2 where A stands for the astrocytes, P stands for pericytes, and E stands for
the hCMEC/D3 cells. Astrocytes were seeded first for two days; then pericytes were layered over
the resulting culture of astrocytes, and allowed to grow for two days; then hCMEC/D3 cells were
seeded over the resulting lawn coculture of astrocytes and pericytes for 6 to 7 days to form a
triculture model of a human BBB.
Note that TranswellTM filter supports were pre-coated overnight with 10ug/mL of poly-L-lysine
before seeding astrocytes to promote the attachment of astrocytes on the surface of a TranswellTM
membrane support. Additionally, 10ug/mL of poly-L-Lysine was applied onto astrocytes culture
before seeding pericytes, and 100ug/mL of type I rat-tail collagen was applied onto the coculture
of astrocytes and pericytes before seeding the hCMEC/D3 cells to promote their attachment on the
lawn coculture of astrocytes and pericytes. Cells were fed with supplemented EBM-2 media on
the apical chamber and alternate astrocytes or pericytes media on the basolateral chamber.
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2.5.3 TEER measurement
TEER values were measured first across filter supports of a free TranswellTM, followed by
monocultures of hCMEC/D3 cells, cocultures of hCMEC/D3 cells directly seeded on pre-attached
astrocytes and lastly across tricultures of hCMEC/D3 cells directly layered over cocultures of
astrocytes and pericytes to form a triculture. TEER-values across filter supports of a free Transwell
TM

containing HBSS buffers, were used to correct values obtained from cell cultures grown on the

apical surface of the TranswellTM membranes. Cell media were replaced with HBSS buffer,
followed by equilibration at room temperature before recording TEER values in cell cultures that
were evaluated in this study.
2.5.4 Test compounds
A set of compounds that represents small and large paracellular permeants was selected to
evaluate and compare the paracellular permeation across mono-, co- and tri-culture methods for
mimicking the BBB in vitro. This set consisted of [14C]-sucrose purchased from PerkinElmer,
[14C]-mannitol purchased from Moravek Biochemicals, [14C]-PEG-4000 purchased from
American Radiolabeled Chemicals Inc., and [14C]-inulin purchased from PerkinElmer.
Sucrose was initially used in making permeability comparisons involving monocultures of
hCMEC/D3 cells, cocultures of hCMEC/D3 cells with pericytes or astrocytes, and the tricultures
of hCMEC/D3 cells layered over cocultures of astrocytes and pericytes. Mannitol was used to
compare paracellular tightness in the monocultures of astrocytes, pericytes, with tightness in the
cocultures of astrocytes and pericytes. PEG-4000 and Inulin-5000 were used to confirm the
observed paracellular tightening in the direct contact triculture model relative to the monoculture.
A comparison of the physicochemical properties for the paracellular permeants used in this study
are listed in Table 4.1.
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2.5.5 Permeability assays under monocultures of the hCMEC/D3 cells
Immortalized hCMEC/D3 cells (frozen at passage 32) were re-grown in a vented T-75 flask in
an incubator set at 37˚C and 5% CO2. The hCMEC/D3 cells were used after three or more passages
in a T-75 flask pre-coated with 100ug/mL collagen. Upon 90% confluency, the hCMEC/D3 cells
were detached from T-75 flask using a solution of a trypsin solution. Calculation of permeability
values was achieved using equations 2.1 and 2.2, where Papparent stands for the apparent
permeability of a molecular permeant across the BBB cell culture layers including the porous
membranes of the filter support, PLayers stand for the effective permeability across the BBB cell
culture layers, and PFilter stands for the permeability value across an empty filter support of a
TranswellTM, VR is the volume of the receiver chamber, CR is the concentration of the BBB
permeant in the receiver chamber at time t, A is the area of the transwell surface onto which BBB
cells layers are attached, and CD0 is the concentration of the BBB permeant in the donor chamber
of a transwell at time t = 0.

1
𝑃𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡

=𝑃

1
𝐿𝑎𝑦𝑒𝑟𝑠

+

1
𝑃𝐹𝑖𝑙𝑡𝑒𝑟

𝑉 𝑋 𝑑𝐶

(Equation 2.1), & 𝑃𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡 = 𝑑𝑡 𝑅× 𝐴 × 𝐶𝑅

𝐷0

(Equation 2.2)
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Table 2.1. The Physicochemical properties for the tested paracellular permeants.
MW = Molecular weight, rH = hydrodynamic radius
Compound

Physicochemical properties

Radiolabel

MW = 182.172 g/mol
Aqu. solubility= 16mg/mL
rH = 3.8Å

14

C

14

C

14

C

14

C-Mannitol
MW = 342.297
Aqu. solubility = 210mg/mL
rH = 4.4 Å

14

C-Sucrose

n

MW =4000g/mol
Aqu.solubility= 630 mg/mL
rH = 16Å

PEG-4000

n

Inulin-5000

MW =5000
Aqu. solubility = NA,
rH = 15Å
14

C
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Trypsin was then removed by centrifugation at 1500 rpm and the re-suspended hCMEC/D3
cells were seeded in triplicates at 8 x 104 cells/cm2 on the collagen-coated apical surface of filter
inserts of a TranswellTM (0.4 um pore size). The hCMEC/D3 monocultures were placed in a sterile
incubator for 7 days and their cell media was changed every 48 hours.
Before performing permeability assays, the hCMEC/D3 monocultures were washed three times
in PBS followed by incubation with HBSS (Hank’s Balanced Salt Solution containing 25 mM
Hepes buffer, pH ~ 7.4) for 15 minutes before carrying out transport studies. At the start of
paracellular permeability experiments, 1.5mL of fresh HBSS buffer was placed in the receiver
chamber of a TranswellTM and 0.5mL of fresh HBSS containing a test radio labelled marker
compound were added at the donor chamber. Paracellular marker concentrations used in this study
were 0.25uCi/mL for mannitol, 0.25 uCi/mL for sucrose, 1uCi/mL for PEG-4000 and 1 uCi/mL
for inulin-5000. Samples from the receiver chamber were collected at 15, 30, 45, 60, 90 minutes
intervals. Transport assays were carried out on rocking plate at 40 rpm. Radioactivity in the donor
samples was detected using a liquid scintillation counter. The rates of mass transfer from the donor
chamber to the receiver chamber were used to calculate permeability coefficients using Equations
2.1 and 2.2.
2.5.6 Permeability assays under cocultures of the hCMEC/D3 cells with pericytes
A direct coculture of hCMEC/D3 cells on pericytes was achieved on the apical surface of a
filter insert as follows: Primary human brain vascular pericytes (HBVP frozen at passage 3) were
re-grown up to passage 5 in a vented T-75 flask positioned inside a sterile incubator set at 37˚C
and 5% CO2 atmosphere. Upon 90% confluency, pericytes were detached from T-75 flask using
a trypsin solution. The trypsin solution was separated from pericytes by centrifugation of the
suspended cells at 1500 rpm.
The resulting pellet of pericytes was re-suspended in media, and subsequently the suspended
cells were plated in triplicates at seeding density of 4 x 104 cells/cm2 on the apical surface of filter
inserts that were pre-coated with 10ug/mL Poly-L-lysine. At the end of 48 hours, cultures of
pericytes were rinsed with HBSS, followed by incubation for 10 minutes with 0.5mL of 100ug/mL
rat-tail collagen type I, at 37˚C and 5% CO2. This collagen solution was then removed before
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plating the hCMEC/D3 cells directly on top of the pericytes layer at a density of 8 x 104 cells/cm2.
The permeability assay was performed on day 7 using sucrose in section 2.4.5.
2.5.7

Permeability assays under cocultures of the hCMEC/D3 cells with Astrocytes

A direct co-cultivation of hCMEC/D3 cells on top of astrocytes that were pre-attached on the
surface of a filter membrane of a TranswellTM was carried out using a similar protocol for the
hCMEC/D3 coculture with pericytes as explained in section 2.4.6. The permeability of sucrose
across the direct coculture of hCMEC/D3 cells with astrocytes, was performed in a similar way to
the hCMEC/D3 monoculture as described in section 2.4.5.
2.5.8 Permeability assays under tricultures of the hCMEC/D3 cells with pericytes and
astrocytes
Direct tri-cultivation of layers of astrocytes, pericytes and hCMEC/D3 were set up on the apical
surface of a TranswellTM filter support as follows. Astrocytes are first plated at 4 x 104 cells/cm2
on filter inserts that had been pre-coated with 10ug/mL poly-L-lysine overnight. At the end of 48
hours, astrocytes were incubated with 0.5mL of 10ug/mL poly-lysine on the apical side for 10
minutes at 37˚C and 5% CO2 atmosphere. Once poly-L-lysine solution was removed, pericytes
were plated on top of astrocytic-layer at a seeding density of 4 x 104 cells/cm2. At the end of 48
hours, the co-culture of astrocytes and pericytes layers was rinsed using HBSS and incubated (on
the apical side) with 0.5mL, 100ug/mL of rat-tail collagen type I for 10 minutes at 37˚C and 5%
CO2. At the end of 10 minutes, the collagen solution was removed and the hCMEC/D3 cells are
plated on top of the co-culture layers at a density of 8 x 104 cells/cm2 to form a full tri-culture
model of the BBB-glial vascular unit. Permeability assays for mannitol, sucrose, PEG-4000 and
Inulin-5000 were performed as described in section 2.4.5.
2.5.9

Statistical Analysis

Results were reported as the means ± SEM and a p-value < 0.05 (*) indicated a significant
difference. Data comparisons were conducted using one tailed student’s T-tests or one-way
ANOVA tests followed by a post hoc Tukey-multiple comparison test to identify specific
differences in the mean values of experimental parameters being compared. In addition, a nonoverlapping 95% confidence interval (CI) was used to establish significant differences in the mean
values where parameters under comparisons were closely spaced.
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2.6

Results and discussion

2.6.1 Selection of the cell-seeding density ratio for the triculture model
Cell seeding densities can have a significant effect on the integrity of a BBB cell-culture model
[Wilson et al., 2015]. The first task in the present study was to select an optimal seeding density
ratio for the direct-contact triculture model of the BBB (see Table 2). Initially, a seeding density
ratio of [(5 x 103A): (5 x 103P): (1 x 105E)] cells/cm2 was selected as a slight modification in the
seeding density ratio first reported in methods involving indirect tri-cultivation of hCMEC/D3
cells with pericytes and pericytes where these cells were separated by a thick filter membrane
[Hatherell et al., 2011]. The seeding densities for astrocytes and pericytes were increased
gradually to obtain an optimal coverage of the filter membrane, which would result in the optimal
lawn of cells onto which the hCMEC/D3 cell layer would form. When the astrocytes and pericytes
seeding density-ratio was increased upto [(4 x 104A): (4 x104P)] cells/cm2, the resulting co-culture
was well attached on the surface of a TranswellTM filter support. The seeding density for the
hCMEC/D3 cells was reduced gradually from 1 x 105 cells/cm2 to 8 x 104 cells/cm2 to avoid
overgrowth in the hCMEC/D3 layer in the triculture model of the BBB system. Ultimately, a
seeding density ratio of [(4 x 104A): (4 x 104P): (8 x 104E)] cells/cm2 was selected due to its good
stability and early increase in TEER values showing a better range of days in which the resulting
triculture would be useful for permeability studies (refer to Table 2.2 for the TEER values).
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Table 2.2. Selection of a seeding density ratio. A = astrocytes, P = pericytes, E = hCMEC/D3 cells
Seeding density

TEER-Max(Ω-cm2),

TEER-Max (Ω-

ratio x 1000

AP co- culture

cm2), triculture

cells/cm2

(5A: 5P: 100E)

47 ± 14

73± 7

(10A: 10P: 100E)

51 ± 10

72± 10

(40A: 40P: 100E)

25 ± 2

81± 3

(50A: 50A: 100E)

41± 6

77± 5

(50A: 50P: 80E)

41 ± 4

73± 3

(40A: 40P: 80E)

43 ± 9

81± 6

TEER values in the coculture of astrocytes and pericytes had similar magnitudes to those
observed in the monocultures of primary hBMECs or the hCMEC/D3 cells (~ 40 Ω-cm2). This
was an intriguing observation suggesting that astrocytes or pericytes may be forming an additional
paracellular barrier in series with the endothelial barrier in the triculture model. The observation
of an electrical resistance in the coculture of astrocytes and pericytes also supports previous studies
by other researchers, which demonstrated the existence of a glial or pericytic barrier in species that
lack a functional endothelial barrier [Frey et al., 1991; Alvarez et al., 2013; Limmer et al., 2014].
The restrictive property in the paracellular permeation was investigated further in this study using
mannitol, (a small paracellular permeant).
There was approximately a two-fold increase in TEER values on day 7 after seeding the
hCMEC/D3 cells on the coculture of astrocytes and pericytes. The observed resistance conformed
to a system of two barriers in a serial configuration; the first electrical resistance experienced in
the hCMEC/D3 layer, and the second experienced in the coculture section made of astrocytes and
pericytes. Surprisingly, the maximum TEER values determined in the direct-contact triculture (~
80 Ω-cm2) were similar in magnitude to those reported using indirect-methods where the
hCMEC/D3 cells are cultured separately together with astrocytes and pericytes to form a triculture
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model of the BBB system [Daniels et al., 2013]. However, the proposed triculture model presents
a novel configuration containing all the principal cellular components of the BBB in direct-contact.
In addition, the proposed configuration would provide space for additional BBB-components such
as neurons or microglia.
2.6.2 Selection of the day for performing permeability assays
A monoculture of hCMEC/D3 layer was prepared at a seeding density of 8 x 10 5 cells/cm2 as
described in section 2.4.5. Permeability coefficients of mannitol were determined in the period
between 24 hours and 244 hours after seeding the hCMEC/D3 cells in a TranswellTM. The resulting
trend indicated a sharp reduction in the permeability of mannitol (~ 2.1 x 10 -4 cm/s to ~ 5.2 x 10 5

cm/s), a 4-fold reduction on day 7. The sharp decrease in the paracellular permeation was used

as an indicator for the formation of tight junctions between adjacent hCMEC/D3 cells in the
monoculture. Furthermore, additional permeability coefficients of mannitol were determined on
day 7, 9 and 10 to confirm that tight junctions remained intact once they formed.
Though the hCMEC/D3 was more restrictive on day 10, permeability assays were run between
day 6 and 9 to avoid the possibility of cell overgrowth of the hCMEC/D3 cell layer. Furthermore,
TEER measurements obtained in the triculture showed maxima on day 7 and a downward trend
after day 9. Thus, again, it was preferred to perform permeability assays on day 7 as both TEER
and mannitol permeability indicated the formation of tight paracellular junctions between
hCMEC/D3 cells around day 7.
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Table 2.3. The formation of tight cell-cell junctions in a monoculture of hCMEC/D3 cells. A sudden reduction in
the mannitol permeability across the hCMEC/D3 culture at the end of 144 hours indicated a reduced cell-cell
junctional space
Time post-

Mannitol

hCMEC/D3 seeding

Permeability (PL)

(hours)
(cm/s)

2.6.3

24

3.0 x 10-4

72

1.4 x 10-4

120

2.1 x 10-4

144

6.3 x 10-5

168

5.2 x 10-5

216

6.0 x 10-5

240

4.0 x 10-5

Microscopic examination in triculture seeding

Step 1: Seeding astrocytes
The microscopic examination was carried out during triculture preparation to ensure that
astrocytes were attached and dispersed well on the surface of a TranswellTM membrane to promote
the formation of a stable basal culture of astrocytes onto which pericytes and hCMEC/D3 cells
would be grown in layers. Astrocytes seeded at a density of 4 x 104 cells/cm2 settled on the surface
of a TranswellTM membrane with good dispersion distances (see Figure 2.3.). At the end of 48
hours, the astrocytes had multiplied to cover a large portion of the TranswellTM membrane. They
also changed their original round morphology to a new morphology that showing sharply pointed
peripheries. However, it was difficult to establish if astrocytes covered the filter membrane
completely. A phase contrast microscope was required for better visualization of the confluency
level on the membrane surface.
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(A)

(B)

Figure 2.3. Step I: Preparation of a layer of astrocytes in the course of seeding a direct-contact
triculture. Prior to seeding, the suspended astrocytes were sheared up and down using a Pasteur
pipette to ensure that no cell clumps were seeded on the transwell membrane. Initially a seeding
volume of .250mL was used to seed astrocytes at a density of 4 x 104 cells/cm2 (panel A). Cells
were left in the sterile hood for 30 minutes in order to settle down on the surface of the membrane.
An additional .250mL of astrocytes media was then added on the apical chamber where the
astrocytes were seeded. The basolateral chamber was filled with 1.5 mL of astrocytes media.
The astrocytes culture was then set in a sterile incubator. The astrocytes culture expanded and
changed the morphology form round circular cells to a sharp-ended morphology at the end of 48
hours (panel B).

Step 2: Seeding pericytes on a basal culture of astrocytes
Pericytes were seeded directly on the attached culture of astrocytes at a density of 4 x 10 4
cells/cm2. Figure 2.4 shows pericytes settling on a basal culture of astrocytes; the sharp-ended
morphology of astrocytes is clearly visible underneath the round dispersed pericytes. Pericytes
multiplied to form a layer that covered the astrocytes layer at the end of 48 hours.
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(A)

(B)

Figure 2.4. Step II: Culturing a layer of pericytes on top of the astrocytes prepared in step I. Pericytes
were prepared in the same way as astrocytes in step I. Panel A shows pericytes settling on a baseculture of astrocytes. Pericytes were dispersed well to avoid formation of multiple layers or
overgrowth. Panel B shows pericytes growing in the co-culture at the end of 48 hours. Though the
new culture looks distinct from the astrocytes culture, it was difficult to visualize a distinct layer of
pericytes due to poor phase contrast in an inverted light microscope.

The original morphology of pericytes changed at the end of two days; the resulting confluent
culture did not reveal cell morphologies associated with astrocytes. Therefore, it was difficult to
obtain focal regions specific to each cell layer regions. A phase contrast microscope was required
for further characterization of superimposed cell cultures prepared in this study.
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Step 3: Seeding the hCMEC/D3 on a basal coculture of pericytes and astrocytes
(A)

(B)

Figure 2.5. Step III: Culturing a layer of hCMEC/D3 cells after step II. Panel A is a micrograph
showing the hCMEC/D3 cells seeded at 8 x 10 4 cells/cm2, on top of a co-culture of pericytes &
astrocytes prepared in step II. The hCMEC/D3 cells was left to grow on a base of astrocytes and
pericytes for 6 days. The resulting triculture was stained on day 7 using hematoxylin. A light
micrograph of the triculture after staining is shown in panel B

The coculture of astrocytes and pericytes in steps 1 and 2 formed a base onto which the
hCMEC/D3 cells were seeded at ~ 8 x 104 cells/cm2 to form the target triculture model of the BBB.
Figure 2.5 shows that the hCMEC/D3 cells settled and dispersed well on a basal co-culture of
pericytes seeded on top of astrocytes. The hCMEC/D3 cells multiplied to form a cobblestoned
layer on day 7 post seeding. The resulting hCMEC/D3 layer was stained with hematoxylin, and
was subsequently photographed under an inverted light microscope. The resulting micrograph in
step 3 shows a characteristic arrangement of BMECs at 100% confluency level [Lim et al., 2011].
2.6.4 Relative paracellular tightness in the BBB triculture
TEER values and permeability coefficients of sucrose were used to compare paracellular
tightness of the mono-, co- and triculture models of the BBB where hCMEC/D3 cells represented
human BBB-endothelial cells. The average TEER values measured in the monoculture of
hCMEC/D3 on day 7 post seeding were lower than values measured in the coculture of
hCMEC/D3 cells with astrocytes and triculture with astrocytes and pericytes (35±5 Ω-cm2, 43±9
Ω-cm2, and 81±6 Ω-cm2 respectively, see Figure 2.6). The higher TEER values in the triculture
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may be due to the inductive effects from astrocytes and/or pericytes. Alternatively, astrocytes and
pericytes may be forming another barrier in series with the hCMEC/D3 barrier juxtaposed on the
underneath coculture of astrocytes and pericytes.
A comparison of the permeability of sucrose across the mono-, co- and tricultures showed a
concomitant decrease in the paracellular permeation from higher values of sucrose permeability in
the hCMEC/D3 monoculture to lower values in the co- and tricultures. A direct coculture of
hCMEC/D3 cells with pericytes led to a decrease in the permeability of sucrose by a factor of 2.5
from (8.7± 0.10) x 10

-5

cm/s in the hCMEC/D3 monoculture, to (3.5±0.25) x 10-5 cm/s in the

coculture with pericytes. Similarly, there was a decrease in the permeability of sucrose in the
coculture of hCMEC/D3 cells with astrocytes, i.e., from a value of (8.7±0.10) x 10-5 cm/s, in the
hCMEC/D3 monoculture, to (3.1±0.13) x 10-5 cm/s in the coculture with astrocytes; this decrease
was similar in magnitude to the decrease observed under coculture of hCMEC/D3 cells with
pericytes.
Though tricultures were expected to show higher paracellular tightness than hCMEC/D3
monocultures or cocultures, sucrose permeability in the triculture was not relatively lower in the
cocultures with astrocytes nor pericytes. Sucrose permeability was (3.0±0.20) x 10-5 cm/s in the
triculture versus (3.5± 0.25) x 10-5 cm/s in the coculture with pericytes and (3.1±0.13) x 10-5 cm/s
in the coculture with astrocytes. Therefore, it seems that paracellular tightening in the hCMEC/D3
barrier may only be increased upto a certain extent; further inclusion of astrocytes or pericytes may
not lead to a further decrease in the permeability of sucrose.
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Figure 2.6. A comparison of paracellular tightness in the mono-, co- and triculture models of
the BBB. TEER values (Panel A) indicated that the direct-contact triculture shows more
resistance to the flux of conducting ions in comparison to the mono- or cocultures (one-way
ANOVA; n = 12, p-values were 0.001 and 0.004 respectively. The higher resistance in the
triculture was confirmed using the permeability of sucrose. The hCMEC/D3 monoculture was
less restrictive to sucrose permeation in comparison to the co-cultures of hCMEC/D3 with
pericytes or with astrocytes and the triculture as shown in Panel B (one way ANOVA; n=6, pvalues were < 0.001 in each comparison where the hCMEC/D3 monoculture was used in the
control experiment). A Turkey’s post hoc test showed that a significant difference in the mean
permeability values existed only between the hCMEC/D3 monoculture control versus co- and
tricultures examined in this study.
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2.6.5 Relative permeability of mannitol in the coculture of astrocytes with pericytes
The permeability of mannitol was tested in the monoculture of astrocytes and cocultures of
pericytes that were directly seeded on top of astrocytes culture to determine whether nonendothelial components of the BBB of any significant paracellular resistance to the flux of small
molecular permeants across the glial vascular unit. Monocultures of astrocytes were used to
represent the astrocytic portion of the BBB system, pericytes monocultures represented the
pericytic component, and the coculture of pericytes and astrocytes were used to test if there was a
synergistic effect in resistance to the permeation of mannitol across non-endothelial cellular
regions of the BBB system.
The apparent permeability of mannitol was higher in the monoculture of pericytes than in the
monoculture of astrocytes or the astrocytes-pericytes coculture. Mannitol permeability was
(3.5±0.29) x10-5 cm/s in the monoculture of pericytes versus (2.7±0.13) x10-5 cm/s in the astrocytes
monoculture, and versus (2.3±0.35) x10-5 cm/s in the coculture of pericytes on astrocytes. The
permeability of mannitol in the monoculture of pericytes was similar in magnitude to the
permeability of mannitol through a free filter membrane of a TranswellTM. Therefore, pericytes
seem not to have offered any effective resistance to the flux of mannitol. Pericytes may be
inducing the formation of a more effective barrier in the astrocytes in a similar way they do in the
hCMEC/D3 cells. The average effective permeability of mannitol across a coculture of pericytes
layered on astrocytes was 6.9 x 10-5 cm/s, (See Figure 2.7 for more discussion of results).
Therefore, future studies are required to establish whether pericytes induce paracellular junctions
(gap or tight junctions) in the astrocytes.
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Figure 2.7. Permeability of mannitol across mono- or co-cultures of astrocytes and
pericytes. The apparent permeability of mannitol is lower in the co-culture of astrocytes
and pericytes in comparison to the astrocytes or pericytes alone (Panel A). The
effective permeability of mannitol (Panel B) in the culture of pericytes could not be
determined since it was equal to that of a free filter membrane containing no cell layers.
The effective permeability of mannitol across layers pericytes and astrocytes in a
coculture, was significantly lower in comparison to monoculture of astrocytes alone as
shown in Panel B (T-test: n = 6, p-value = 0.002)
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2.6.6 Size-dependent permeability of paracellular marker compounds
The BBB shows a size-selective paracellular transport whereby small hydrophilic molecular
permeants may diffuse through paracellular junctions more easily in comparison to the larger ones
[Nitta et al., 2003; Yanagida et al., 2017]. In the present study, permeability coefficients of
hydrophilic permeants with varying hydrodynamic radii were determined under the monoculture
and triculture methods for mimicking the BBB in a TranswellTM. Two categories of molecules
representing either small or large hydrophilic molecules were used to compare the effect of
molecular size on the paracellular permeation rates through a monoculture of hCMEC/D3 cells
and through the triculture of hCMEC/D3 on a lawn of pericytes and astrocytes.
Mannitol and sucrose that were used in the first category of paracellular permeants, representing
small hydrophilic drugs such as atenolol and nadolol that may cross a leaky human BBB via
paracellular routes to cause neurotoxicity. PEG-4000 and inulin-5000 used in the second category,
representing large-sized pharmaceutical excipients that should not diffuse through tight-junctions
of the BBB-endothelium. Figure 2.8 shows that the triculture model of the BBB is more restrictive
than the monoculture for the two categories of compounds examined in this study.
The permeability of mannitol in the triculture model was reduced by a factor of 1.5; sucrose
permeability was reduced by a factor of 2.4; PEG-4000 permeability by a factor of 4.5 and Inulin5000 by a factor of 8. Note that, unlike the hCMEC/D3 monoculture, the triculture model showed
a size-dependent seiving property. Mannitol and sucrose had similar permeability values (i.e., 3.8
x 10-6 cm/s, and 3.6 x 10-6 cm/s) respectively in the triculture, perhaps because they have similar
hydrodynamic radii (3.8Å and 4.4Å respectively). PEG-4000 had a slightly higher permeability
value than inulin-5000 under the triculture model (2.1 x 10-6 cm/s and 2.6 x 10-6 cm/s respectively)
even though PEG-4000 has a slightly larger hydrodynamic radius than inulin-5000.

This

observation indicates that there may be additional physicochemical factors, other than
hydrophilicity and hydrodynamic radii that determine selectivity in the paracellular permeation of
hydrophilic molecules across cellular barriers of the BBB system.
Overall, the triculture model was more restrictive against permeation of the tested hydrophilic
permeants than the monoculture model that offer a partial representation of the BBB system. Both
small and large molecules were more restricted in the triculture model in comparison to the
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monoculture. On the scale of 100% permeation, sucrose is at 83%, mannitol at 63% in the
monoculture.
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Figure 2.8. Size-dependent reduction of paracellular permeability through the triculture. In
comparing mono- and tri-cultures, the decrease in permeability was 1.5-fold for mannitol, 2.4fold for sucrose, 4.5-fold for PEG-4000, and 8-fold for Inulin-5000. The larger compounds
would be much more restricted in the triculture than in the monoculture models of the BBB
system. T-tests indicated a higher paracellular tightening in the triculture model for all four
marker compounds employed in this study (n = 5, p-values were less than 0.05 in all the cases)

In the triculture, sucrose permeated at 38.5% level, while mannitol permeated at 36% level.
Therefore, the triculture model may be more physiologically representative of the human BBB in
vivo since it exhibited higher resistance to the flux of small hydrophilic molecules, sucrose and
mannitol, which are on the size scale of small hydrophilic drugs that may traverse paracellular
junctions of the human BBB to cause neurotoxicity. PEG-4000 and inulin-5000 would be
classified as non-permeants under the triculture method, due to their low levels in permeation rates
(2.1 % permeation rate for PEG-4000 and 2.6 % rate for inulin-5000).
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2.7

Conclusions

The study presented in this chapter showed that, contrary to the popular belief that astrocytes
and pericytes only play a supporting role for the BBB-endothelium, together these non-endothelial
cells might also form a physiological barrier to the flux of a small paracellular permeant such as
mannitol and sucrose that are on the size scale of small hydrophilic drugs. A triculture model of
the human BBB prepared by seeding a layer of hCMEC/D3 cells on a pre-established base
coculture of astrocytes and pericytes leads to the formation of a more physiologically
representative model of the human BBB in TranswellTM chambers. If the triculture is used in
permeability screens of hydrophilic drugs, sucrose and mannitol permeability values should be
used as references to identify hydrophilic compounds with high potential for good permeability
across the human BBB, while permeability values of PEG-4000 and inulin-5000 should be used
to identify hydrophilic compounds with low permeability through the human BBB.
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CHAPTER 3.
ANALYSIS OF THE MULTILAYERED
CONFIGURATION OF THE TRICULTURE MODEL OF A HUMAN
BLOOD-BRAIN BARRIER

3.1

Summary

Background and objective: Current in vitro methods for mimicking the Blood-Brain Barrier
(BBB) are often not physiologically representative of the in vivo neurovascular unit; thus, they do
not allow optimal interactions between principle cellular components (astrocytes, pericytes, and
the brain microvessel endothelium) that are layered in vivo. Conventional models do not enable
physical contacts and proximal association between the BBB endothelium, pericytes and
astrocytes, which combined play a synergistic role in the regulation of the restrictive barrier
properties. The objective of this study was to examine the cellular configuration of a directly
layered triculture model of the human BBB and make a comparison to the cellular configuration
from a reference TEM micrograph of a human BBB as presented in the literature.
Methods: The overlay of cell layers, as described in Chapter 2, was examined using a phase
contrast microscope during different stages of preparation of a triculture by imaging cellular
morphology of the first seeded layer corresponding to astrocytes, then the second layer of
pericytes, and finally the third seeded layer of hCMEC/D3 cells. Cross-sectional features of the
BBB cell layers were examined using a Transmission Electron Microscopy (TEM) and were
compared to the reference cross-sectional images of a human glial BBB unit. Lastly, the formation
of distinct optical sections in the triculture was examined using a confocal microscope.
Results: There was an overlay of distinct cell layers in the course of seeding the triculture. The
first layer showed characteristic features corresponding to the astrocytes, the second layer showed
mixed features corresponding to pericytes and astrocytes, the third layer showed features
corresponding to the hCMEC/D3 cells. Cross-sectional TEM micrographs of the triculture showed
localization of the hCMEC/D3 cells at the top layer, a mix of pericytes and astrocytes in the middle
layer, and a distinct localization of astrocytes at the bottom layer. A Z-scan using confocal
microscopy revealed the existence of two distinct optical sections in the triculture model; the first
optical sections showed features of hCMEC/D3 cells, and the second showed mixed features of
astrocytes and pericytes.
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Conclusion: The present triculture model of the BBB contains three layers of cells. The first top
layer consisted of the hCMEC/D3 cells, the second layer showed a mix of astrocytes and pericytes,
and the base-layer corresponded to the astrocytes.
Keywords: Blood-Brain Barrier, Phase-Contrast Microscopy, Bright-Field Transmission Electron
Microscopy, Confocal Fluorescence Microscopy, Optical Sectioning

3.2

Introduction
The Blood-Brain Barrier (BBB) refers to a set of mechanisms used by the brain endothelial

capillaries and the surrounding glial barrier (i.e., mainly the astrocytes) to regulate the exchange
of molecules from capillary lumen to the brain parenchyma and vice versa [Hawkins and Davis,
2005; Banerjee and Bhat, 2007]. Pericytes form direct connections with the BBB endothelium
while astrocytes mostly form proximal associations with the BBB endothelium [Banerjee and
Bhat, 2007]. Both pericytes and astrocytes have an influence on the expression and function of
tight junctions at the BBB endothelium [Daneman et al., 2010; Cabezas et al., 2014]. Furthermore,
direct connections and channels formed between pericytes and BBB endothelium facilitate a
bidirectional transfer of ions and small molecules from the BBB endothelium into pericytes,
thereby mediating a selective exchange between BBB endothelia and pericytes or astrocytes
[Larson et al, 1987; Winkler et al., 2011]. Such exchanges suggest that small drug molecules or
drug delivery systems may also be selectively exchanged from BBB endothelia into pericytes and
astrocytes before reaching brain parenchyma. The BBB endothelium is almost completely covered
by a layer of astrocytes that wrap pericytes around the endothelial capillary [Hawkins et al., 2006;
Herland et al., 2016]. This complex configuration may be responsible for the formation of a highly
selective barrier to the permeation of novel CNS drugs/drug delivery systems into the brain
parenchyma.
In vitro cell culture models of the BBB system are often used in studies related to the
permeation properties of drug molecules across the human BBB [Naik et al., 2012; The
International Transporter Consortium, 2010]. In conventional methods, BMECs are cultured on
TranswellTM support or a lab-chip to form a monoculture that represents only the endothelium
portion of the BBB, while the important direct physical arrangements and connections that exist
between the BBB endothelia and the BBB astrocytes or pericytes are omitted or not fully
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optimized. The astrocytes and pericytes cultured on the basolateral surface are largely separated
from the endothelial cells by a thick filter support that limit physical association between all the
three types of BBB cells, i.e., BMECs, astrocytes and pericytes [Hatherell et al., 2011; Brown et
al., 2015]. Thus, a novel method involving direct seeding of all the principal cellular components
of the BBB system on the same side of a filter support would be more physiologically
representative of the in vivo-BBB. However, a challenging task would be in establishing if a direct
overlay of all the principal BBB cells would result in a multicellular configuration similar to that
of the glial-vascular unit at the BBB in vivo.
One of the goals in the present study was to analyze the spatial arrangement of layers
corresponding to the different types of the BBB cells overlaid in vitro in order to mimic the BBB
in a more representative configuration that would allow for free interactions between astrocytes,
pericytes and the hCMEC/D3 cells. To achieve this goal, cross-sectional TEM micrographs of a
direct contact, layered triculture model of the BBB were compared to a reference micrograph of a
human BBB as published in the literature. Note that there is a limited number of TEM micrographs
for the human BBB in the literature. In most cases, cross-sectional TEM micrographs correspond
to a rat BBB. Since the study described in this chapter used only human-BBB cells, it was rational
to rely on a TEM micrograph obtained from a human BBB rather than that of the rat.
There are notable differences between a human BBB specimen and a rat-BBB specimen. The
TEM micrographs of a rat BBB (Figure 3.1) shows a layer of small transparent pericytes
surrounding a relatively larger capillary-endothelium [Farkas et al., 2001]. In the same micrograph,
circumferential, fairly transparent astrocytes are observed covering pericytes and the endothelium
capillary completely forming a supporting layer for the capillary to form within. Astrocytes are
separated from pericytes and the endothelium by a thin extracellular space [Farkas et al., 2001].
On the contrary, a close look at a reference TEM micrograph of a human BBB (Figure 3.2) shows
pericytes that have similar size and morphology to adjacent BBB endothelium [Garbuzova-Davis,
2012].
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Figure 3.1. A reference TEM micrograph of a Blood-Brain Barrier specimen from
the rat. Panel A represents the actual micrograph and Panel B is a pictorial
representation of the micrograph in panel A. The cross-sectional BBB micrograph
of a rat, as presented in the micrograph, consists of a single endothelium that forms
a lumen of the blood capillary. The BBB endothelium locks its peripheral ends by
forming tight-junctions. The BBB endothelium shows prominent cell organelles in
the cytoplasm including mitochondria, vacuoles, nucleus, and the nucleolus.
Numerous regions of the capillary lumen seem to be budding off the endothelial
surface. Pericytes that surround the BBB capillary seem to be relatively smaller than
endothelium. The surrounding astrocytes are more transparent to the beam of
electrons, and they have a heterogeneous morphology that lack prominent nuclei
and other cell organelles [Farkas et al., 2001, image reproduced with permission
from Elsevier]
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Figure 3.2. A cross-sectional TEM micrograph of a human BBB. The BBB
capillary is associated with a single pericyte. The BBB endothelium forms
cytoplasmic extensions that loop to form a capillary lumen stabilized by
tight junctions. Pericytes do not form a lumen nor tight junctions similar in
a similar way to the BBB endothelium [Garbuzova-Davis et al., 2012,
image reproduced with permission from Elsevier].

Thus, a distinction between a human BBB pericyte from a human BBB endothelium may not be
achieved in the TEM micrographs of a human BBB triculture model, where pericytes and
endothelial cells could be highly similar in size and morphology.
In cases where the distinction between pericytes and endothelium is not so apparent, one may
rely on the examination of additional ultrastructural features such as the type of cell-cell junctions
between adjacent endothelial cells or differences in the size or structure of select internal cell
organelles. For example, a layer of endothelial cells at the top section of a triculture model would
be stabilized by tight junctions formed when two adjacent endothelial cells form contacts while
similar cell-cell connections/associations would not be consistently observed between pericytes or
astrocytes in adjacent positions. The middle layer composed of pericytes would be less stable, and
more disordered in space in comparison to the endothelial layer due to lack of stabilizing tight
junctions between two adjacent pericytes.
On the contrary, astrocytes would be stabilized on the surface of a filter support by the poly-Llysine coating that was applied a few hours prior to seeding on the TranswellTM filter support. In
addition, astrocytes would have a distinct morphology from pericytes and endothelial cells, and
therefore would be more easily distinguished from the other cells in the triculture model. A close
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examination of a thin cross-sectional specimen from the BBB triculture would reveal characteristic
features corresponding to each cell type in the multilayered triculture.
As noted earlier, the distinction between BBB endothelium and the pericytes may be difficult
to achieve just based on size or morphological features. In that case, an alternative approach
involving fluorescence imaging may be used to establish a difference in the fluorescence properties
of pericytes and endothelial cells in a triculture setting. Briefly, the cytoskeleton of each cell type
(the hCMEC/D3, pericyte, and astrocyte) would be labeled fluorescently with rhodhaminephalloidin (a fluorescent dye for mapping the F-actin distribution inside a cell) and the triculture
would be imaged in a confocal microscope to see if distinct cell features would be visible at
discrete optical sections. If each cell layer fluoresces differently, then a confocal microscope would
reveal a triculture configuration in which astrocytes form the first layer, pericytes the second and
hCMEC/D3 cells the third, in a Z-stacking mode.

3.3

Hypothesis

The triculture model of the BBB shows characteristic features for the hCMEC/D3 cells in the top
layer, for pericytes in the middle layer, and for astrocytes in the basal layer to mimic the cellular
configuration of the human glial-vascular unit/the BBB.

3.4

Cell specific features

3.4.1 Cell specific morphologies
If there were a difference in the cell morphologies of astrocytes and pericytes or the
hCMEC/D3 cells, then, a layer of hCMEC/D3 cells would reveal an arrangement of cells and
morphologies that would be distinct from that of pericytes or the astrocytes. However, as
mentioned before, pericytes seeded in an in vivo-like environment may exhibit a morphology like
that of a BBB endothelium. In this study, the formation of distinct cell layers would be monitored
by a phase contrast microscope during preparation of a BBB triculture model, in a LabTek II
chamber slide. A further distinction between astrocytes, pericytes and the hCMEC/D3 layers
would be achieved by using TEM micrographs of thin cross-sections prepared from the triculture
specimen. TEM micrographs of cross-sectional thin specimen developed from monocultures of
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astrocytes, pericytes and the hCMEC/D3 cells would be used as control TEM micrographs to
identify the relative positions of each type in the triculture model.
3.4.2 Cell-cell junctions
There are distinct types of cell-cell junctions that would form in each cell-layer of the BBB
triculture model. The top layer of hCMEC/D3 was expected to form a continuous arrangement of
cells with tight junctions that stabilize the endothelial layer spreading on a basement of astrocytes
or pericytes. The formation of tight cell-cell junctions would not form among pericytes in the
middle section. However, the occasional formation of peg/socket junctions between pericytes and
the hCMEC/D3 cells was expected since such junctions form between BBB-endothelia and BBBpericytes in vivo.
While extensive cell-cell connections between astrocytes and the BBB endothelium are not
common, it is currently established that astrocytes form extensive gap junctions between
themselves in order to propagate chemical signals between neurons and perhaps the BBB
endothelium [Anders et al., 2014; Chen et al., 2016]. The formation of such gap-junctions among
the BBB astrocytes may cause astrocytes to act as a secondary barrier that supports the protective
endothelial part of the BBB system, especially under conditions such as stroke where the
endothelial BBB is compromised [Kassner and Merali, 2015].
3.4.3 Internal cell organelles
It was expected that different types of cells that make up the BBB system would manifest
differences in size and distribution of their internal organelles (see Figure 3.3 for details on the
structure of cell organelles). The hCMEC/D3 cells were expected to contain characteristic
Vesiculo-Vacuolar Organelles (VVOs) that are responsible for trafficking macromolecules across
most endothelial barriers [Dvorak et al., 2000]. Unlike the hCMEC/D3 cells, pericytes were not
expected to show extensive VVOs. Instead, pericytes were expected to show a swollen nucleus
that occupies much of the cytoplasm [Hurtado-Alvarado et al., 2014]. In addition, pericytes would
show a characteristic larger nucleolus in comparison to the relative nucleolus in the hCMEC/D3
cells. Additional differences in the size, morphology and distribution of internal cell organelles
between pericytes and hCMEC/D3 cells could be established from their monoculture TEM
micrographs and used where possible to distinguish the two cell types in a triculture setting.
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Cell organelles in the astrocytes are small and sparsely distributed in the cytoplasm; thus,
astrocytes are relatively more transparent to the incident beams of light or electrons when imaged
under light or electron microscopes [Garcia-Cabezas et al. 2016; Hayakawa et al., 2016]. An
alternative visualization for the size and distribution of internal cell organelles, either in the
monoculture controls or the triculture, would involve fluorescence imaging. Fluorescent labelling
of the F-actin in each cell type would reveal cytoskeletal structures, where differences in the pattern
of F-actin expression for each cell type would be used to establish the localization of each cell type
in the optical sections of a triculture specimen.

Figure 3.3. A schematic representation for the cross-sectional features of a typical human
cell grown on a filter membrane: (1) Nucleolus, (2) Nucleus, (3) Cytosol, (4) Endoplasmic
reticulum, (5) Golgi body, (6) Vacuole, (7) Microfilament, (8) Mitochondrion, (9)
Microtubules (10) Junctional complex, (11) Filter-support (12) Cell membrane. Sizes and
distributions of the cell organelles can vary across different types of cells depending on
their functions or environment.

3.5

Materials and imaging techniques

3.5.1 Materials
Astrocytes, pericytes, the hCMEC/D3 cells, TranswellTM chambers, poly-L-lysine, collagen,
trypsin, PBS, astrocyte growth media, pericytes growth media, P/S solution, Astrocyte growth
supplement AGS, pericyte growth supplement PGS, EBM-2 media and supplements, LabTek II
slide chambers, 4% paraformaldehyde, acetone, rhodhamine phalloidin, bovine serum albumin
BSA, and Fetal Bovine Serum FBS, Sorens phosphate buffer, glutaraldehyde, osmium tetroxide,
ethanol, epoxy solution, toluidine blue dye-solution, uranyl acetate and lead citrate solutions.
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3.5.2 Imaging techniques
3.5.2.1

A brief description of phase contrast microscopy

When a beam of light is focused on a cell, a portion of it follows an unaltered path through
the cell, while a different portion of it is absorbed and diffracted by the cell organelles. Intensity
of the light following an unaltered path through the cell is slightly higher than that of the light
absorbed and diffracted by the cell organelles. A phase contrast microscope is utilized to modify
the phase amplitudes of light transmitted through the cell, thereby generating contrast images that
have bright and dark regions. The observed brightness would be inversely proportional to the cell
density in the light path. Highly dense regions inside the cell, such intracellular region, would
appear darker than the peripheral regions that are mainly composed of lipid membranes [Zernike,
1955].
Therefore, phase contrast microscopy was utilized as a density mapping technique in which
cell morphologies in confluent or near confluent monocultures could be revealed. Phase contrast
micrographs taken from monocultures of astrocytes, pericytes and the hCMEC/D3 cells were
compared to the micrographs obtained from the triculture containing layers of all the three types
of the BBB cells. A phase contrast micrograph of the triculture specimen was expected to show a
highly contrasted optical section corresponding to the confluent layer of hCMEC/D3 cells. The
control monoculture of hCMEC/D3 cells would show a cobble stone arrangement similar to the
one obtained for the hCMEC/D3 layer in the triculture model of the BBB.
3.5.2.2 Application of phase contrast during preparation of a BBB triculture
Surface morphologies corresponding to each cell-layer formed in the course of preparing a
triculture model of the BBB, were detected with a Nikon TiS phase contrast microscope. In the
first step, astrocytes were seeded on the surface of a LabTek II slide at a density of 4 x 10 4
cells/cm2. The astrocyte culture was maintained in a sterile incubator (set at 5% CO2 and 37˚C) for
48 hrs. At the end of 48hrs, the culture was rinsed three times with PBS and fixed using 4%
formaldehyde in PBS solution for 15 minutes. The culture was washed three times with PBS again
to remove the fixative. Phase contrast images of this astrocytes monoculture were collected with a
Nikon TiS microscope.
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In the second step, pericytes were seeded at 4 x 104 cells/cm2 directly on top of pre-cultured
astrocytes (at the end of 48hrs) as described in step 1. The resulting coculture was fixed with 4%
formaldehyde at the end of 48hrs and imaged under Nikon TiS. In the third step, the hCMEC/D3
cells were seeded (at 8 x 104 cells/cm2) directly on a coculture lawn of the astrocytes and pericytes
that was prepared as explained in step 2. The resulting triculture was fixed in 4% formaldehyde
on day 7 after seeding hCMEC/D3 cells. The triculture was imaged under Nikon TiS microscope.
3.5.2.3 A brief description of transmission electron microscopy (TEM)
Thin sections of cell-cultures can be imaged in TEM to examine morphological and ultrastructural characteristics of cells [Winey et al., 2014]. Briefly, an incident beam of electrons is
focused on a thin cross-sectional specimen of a cell culture, and the scattered electrons are
refocused on a detector positioned in the first image focal plane. To visualize various internal
features of cells under analysis, a fixed cell-culture specimen is stained with various contrasting
agents to allow for a contrasted visualization of specific cell organelles such as nucleus,
mitochondria, vacuoles, ribosomes, etc. The stained specimen is embedded in a polymer resin,
followed by cutting thin cross-sections that can be mounted on a TEM grid for imaging.
3.5.2.4 Application of TEM in imaging the BBB triculture
Three types of cells that form the BBB system (i.e., astrocytes, pericytes and the hCMEC/D3
cells) were cultured on TranswellTM chambers at the seeding densities described in Chapter 2.
Briefly, monocultures of the hCMEC/D3 cells (8 x 104 cells/cm2) for seven days, pericytes (4 x
104 cells/cm2) for two days, and astrocytes (4 x 104 cells/cm2) for two days to provide control TEM
micrographs for the analysis of cell arrangement in the triculture specimen. For the triculture on a
TranswellTM chamber, astrocytes were cultured first at a seeding density of (4 x 104 cells/cm2) for
two days, followed by pericytes at a density of (4 x 104 cells/cm2) for two additional days, and
then by hCMEC/D3 cells at (8 x 104 cells/cm2) for 6 days prior to electron microscopy fixation.
All cell-culture samples were fixed with 2.5% glutaraldehyde solution for at least 1 hour. Sorensen
phosphate buffer was used to wash the cells three times to remove glutaraldehyde.
A buffer solution containing 1% osmium tetroxide was applied into the samples for 1hr to
allow for high contrast images. Sorensen phosphate buffer was used to rinse off excess OsO4.
Samples were then dehydrated with a grades series of ethanol (see publication by Ye et al., 2014

63
for a detailed protocol). Following dehydration, a solution mixture of epoxy resin and ethanol (1:1,
V/V) was added to the apical and basolateral chambers of the TranswellTM for 1 hour, using 0.5mL
and 1.5mL respectively. At the end of 1 hour, a 100% epoxy solution was added to the prepared
specimens followed by incubation at 37˚C to ensure a complete evaporation of ethanol. Cell
cultures in TranswellTM chambers containing the resin solution were then placed in an oven at 65˚C
for a period of 24 hours to allow for resin polymerization and embedment to take place. At the end
of 24 hours, the cell cultures embedded in epoxy resin were used to obtain thin cross-sectional
specimen for the TEM analysis.
Briefly, thin cross-sections of the cell culture specimens were prepared using a microtome as
described in the methods by Ye et al., 2015. Copper grids of 3.05 mm and 200 square mesh were
used for mounting TEM sections. Some of the microtomic sections were stained with toluidine
blue and analyzed under a light microscope. Copper grids for TEM-specimen were further stained
with 2% uranyl acetate, first for 20 minutes, followed by additional staining with 0.4% lead citrate
for an additional 1 hour. TEM images were then acquired using a FEI Tecnai G2 T20 electron
microscope equipped with a LaB6 source of electron beam, operating at 100 kV.
3.5.3 A brief description of the fluorescence microscopy
Optical sections of a fluorescent tissues or cell cultures can be visualized using a confocal
microscope [Conchello et al., 2005]. The approach allows one to look at different sections of a
tissue culture along the Z axis without carrying out actual/physical sectioning. Briefly, specific
proteins/protein filaments are stained with a fluorescent antibody which can be excited with a laser
light to give visible fluorescent emissions that are detectable with a CCD camera in a confocal
microscope. Therefore, cell specific arrangement of proteins or protein filaments may be
visualized in a confocal microscope. In this study, the structure and arrangement of the F-actin
protein was expected to be different in each of the cell type used in the development of a BBB
multicellular model consisting of astrocytes, pericytes, and the hCMEC/D3 cells. The F-actin, a
cytoskeleton protein, was stained with rhodhamine phalloidin, a commonly used fluorescent dye
for visualizing the skeletal structure of cells.
First, the F-actin arrangement in the monocultures of astrocytes, pericytes and the
hCMEC/D3 cells would be analyzed and used as controls in the optical sectioning of a
multicellular culture containing a superimposed layer of hCMEC/D3 cells (at the top) on the basal
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layers of pericytes followed by astrocytes. It was expected that the multicellular culture would
show optical sections corresponding to the astrocytes, pericytes and the hCMEC/D3 layers at
distinct focal regions. A detailed description of this analysis is described in the proceeding
subsection.
3.5.3.1

Application of confocal microscopy in visualizing optical sections of a BBB
triculture

Monocultures of hCMEC/D3 cells, pericytes and astrocytes were cultivated in the LabTek
slide chambers at a density of 4 x 104 cells/cm2 for two days. A triculture of hCMEC/D3 with
pericytes and astrocytes was seeded using a density ratio of (4 x 104 A: 4 x 104 P: 8 x 104 H)
cells/cm2 where A stands for the astrocytes, P for the pericytes and H for the hCMEC/D3 cells.
Briefly, astrocytes were seeded for 48 hours; then pericytes were seeded on top of the astrocytes
for another period of 48 hours; and hCMEC/D3 cells were then overlaid on the coculture of
astrocytes and pericytes for a period of six days. Both mono- and tri-cultures were fixed with 4%
formaldehyde. All the cultures (mono- and tri-cultures) were then washed three times with PBS,
followed by permeabilization with cold acetone at -20˚C for 2 minutes on ice. The cell culture
samples were then washed and rinsed with cold PBS at least three times, followed by air-drying at
room temperature.
Dried specimens were incubated with 200mL of diluted rhodhamine phalloidin solution
(150nM). Specimens were wrapped in aluminum foil for a period of 30 minutes at room
temperature. Excess rhodhamine phalloidin was then washed off three times with PBS. These
specimens were dried again in air and wrapped in aluminum foil to reduce exposure to external
light. Visualization of the F-actin was achieved by fluorescence excitation at a wavelength of
550nm, and emission detection at a wavelength of 580nm using a confocal microscope (Nikon
Eclipse TE200).
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3.6

Results

i) Phase contrast images of the cell layers during preparation of a BBB triculture:

(A)

(B)

(C)

Figure 3.4. Formation of distinct cell-layers during BBB triculture preparation. (A) Sub-confluent layer of astrocytes
formed after two days (48 hours) shows cells with a characteristic morphology for the astrocytes. (B) A sub-confluent
layer of pericytes laid over the astrocytes layer at the end of two days (48hrs) post-seeding. (C) A confluent-layer of
hCMEC/D3 cells laid over the underneath coculture of astrocytes and pericytes (prepared as described in panels A
and B) at the end of six days post-seeding.

66
ii) TEM micrographs showing ultrastructural features in a monoculture of hCMEC/D3
cells:

(A)

(B)

(C)

Figure 3.5. Ultrastructural features in the monoculture of hCMEC/D3 cells. Panel A shows
tight junctions formed between two adjacent hCMEC/D3 cells (red arrow) and an exosome
budding off the hCMEC/D3 cell (blue arrow). Panel B shows an overlapping cell-cell
junction forming a minute contact points (orange arrow) and a larger nucleus occupying
most of the cytoplasmic space (white arrow). Panel C shows the formation of numerous
vacuoles (green arrow), a large exosome (blue arrow) and a fusing cell-cell junction
(orange arrow).
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iv) TEM micrographs showing ultrastructural features in the monoculture of pericytes:

(A)

(B)

(C)

Figure 3.6. Ultrastructural features in the monoculture of pericytes. Panel A shows wide cell-cell
junctions between two adjacent pericytes (orange arrow), and a highly transparent vesicle containing
granular materials in its lumen (green arrow). Panel B shows an overlapping cell-cell junction between
two adjacent pericytes (orange arrow), a prominent rough endoplasmic reticulum (red-pink arrow)
and highly transparent exosomes (blue arrow). Panel C shows a prominent nucleolus structure at the
center of a pericyte nucleus (dark blue arrow).
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v) Ultrastructural features in the monoculture of astrocytes:

{A)
(A)

(B)
{B)

{C)
(C)

Figure 3.7. Ultrastructural features in the monoculture of astrocytes. Panel A shows a stellate
projection from the body center of an astrocyte (orange arrow) and a swollen body center (blue
arrow). Panel B shows an elongated projection from the body-center of an astrocyte. Panel C shows
a swollen end-section of an astrocyte (green-yellow arrow)
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vii) Ultrastructural features in the triculture model of the BBB, Part I:

(A)
E or P
E
PN

PN

A

PN

A

(B)

E
P

AB

Figure 3.8. Cross-sectional arrangement of cells in the triculture model, part I. Panel
A shows a multicellular structure composed of closely associated cells at the top layer,
which could be endothelial (E), or pericytes (P). The middle section in Panel A contains
dispersed cells containing a prominent nucleus (PN); these could be disordered
pericytes separated by a swollen astrocyte (A) between them. The bottom layer in panel
A consists of cells lacking a prominent nucleus, or formation of vesicles; these could
be astrocytes with sharp stellate ends. Panel B shows a well-contrasted micrograph of
the triculture model. Note that the top layer of cells formed a continuous thin membrane;
this is a property of BMECs/BBB endothelium. Also note that though certain cells in
the middle section resemble endothelial cells at the top, they do not form a continuous
wall; this is a property of pericytes (there is also a large nucleolus in the cells assigned
as pericytes). There is a large extracellular space denoted by a double-headed yellow
arrow in the micrographs. This space could be due to the formation of excess
extracellular matrix.
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ix) Ultrastructural features in the triculture model of the BBB, Part II:

(A)

(B)

(C)

Figure 3.9. Cross-sectional arrangement of the BBB cells in the triculture model, part II. Panel (A) shows
junctional contacts between two endothelial cells (red arrow), and a high population of vacuoles (green) in
the two adjacent endothelial cells. The middle and basal layers in panel (A) show prominent mitochondria
characteristic of astrocytes at the BBB in vivo (maroon arrow). Panel (B) shows middle and basal layers
containing cells with prominently large nucleus and nucleolus (dark blue arrow). Cells in the basal layer of
panel (B) formed widened cell-cell junctions (white arrow). Panel (C) shows cells that form a continuous
cell layer (characteristic of BMECs, see red arrow) at the top layer, a cell in the middle layer that lacks
connections with adjacent cells (a characteristic of pericytes) and a basal layer of cells that have long sharp
projections, lacking prominent vesicles (a characteristic of astrocytes)
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x) The expression pattern of F-actin filaments in the cellular components of the BBB
(astrocytes, pericytes and the hCMEC/D3):

(A)

(B)

(C)

Figure 3.10. Fluorescent patterns of F-actin in the cytoskeletons of astrocytes (Panel A), pericytes (Panel B)
and the hCMEC/D3 cells (Panel C). The fluorescence pattern in the astrocytes is more diffuse in a pattern that
shows a stellate morphology (Panel A). The fluorescence pattern in the pericytes showed a discrete arrangement
of the F-actin bundles (Panel B). The hCMEC/D3 cells showed a more diffuse fluorescent pattern reflecting
their spindle-shaped morphology (Panel C)

xi)The expression pattern of F-actin filaments in the assembled triculture

(A)

(B)

Figure 3.11. Fluorescent optical sections in the BBB triculture. Panel A shows a
faint optical section showing the expression pattern of F-actin in the hCMEC/D3
section. Panel B shows a clearer optical section showing mixed features of
astrocytes and hCMEC/D3 cells, all projected in the same plane
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3.7

Discussion
In vitro methods for mimicking the BBB physiology are needed in programs related to CNS

drug discovery and development [Jeffrey et al., 2010; Aday et al., 2016; Toth etal., 2017]. Many
(if not all) conventional in vitro static methods lack a direct overlay of the BBB endothelium over
astrocytes and pericytes to achieve a physiologically representative configuration. Here we
characterize a novel method used to mimic the BBB by culturing a layer of hCMEC/D3 cells
directly on a layered coculture composed of pericytes and astrocytes. Various microscopic
techniques were utilized in the visualization of cell morphologies, arrangements, internal
characteristics, and subsequently, the cross-sectional arrangement of cells in the triculture model
of the BBB. The aim of this study was to compare the physical characteristics in the triculture
model and those of a BBB specimen obtained in a literature source.
3.7.1

Cell morphologies and arrangements during preparation of a triculture model of
the BBB

Three distinct cell morphologies were expected in the course of preparing a triculture
composed of a layer of astrocytes in the base, pericytes in the middle and the hCMEC/D3 cells at
the top. A sub-confluent layer of astrocytes formed at the end of 48 hours after seeding at 4 x 104
cells/cm2 on a LabTek II chamber slide. The astrocytes layer stayed in a sub-confluent state even
after culturing for 7 days. Astrocytes had a stellar morphology with long slender terminal
projections (see Figure 3.4-A). Similar morphologies and growth patterns in the astrocytes
monocultures have been reported in other literature reports [Zaheer et al., 2002; Velandia-Romero,
2016]. Pericytes seeded at 4 x 104 cells/cm2 directly on the culture of astrocytes, formed a layer of
cells that covered the astrocytes culture to form a new distinct layer (see Figure 3.4-B). The new
layer of pericytes did not show visible foot processes. Instead, pericytes in the new layer were
more round with enlarged regions corresponding to the characteristic prominent nuclei of
pericytes. In addition, the pattern of the enlarged cells were arranged sparsely in the layer.
The observation of enlarged parts in certain areas of the pericytes layer is consistent with
previously published reports on the morphology of pericytes, where a large nucleus occupies much
of the cytoplasmic space to show a round “swollen” center [Nakano et al., 2000; Shi et al., 2008;
Armulik et al., 2011]. When the hCMEC/D3 cells were plated directly onto the new pericytes
layer, at 8 x 104 cells/cm2, they formed a distinct layer showing highly contrasted bright and dark
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regions at the end of 6 days (see Figure 3.4-C). The hCMEC/D3 layer formed in the resulting
triculture with characteristics of the confluent endothelial monocultures as reported in numerous
publications [Jinga et al., 2000; Lucq et al., 2000]. Cells in a confluent layer of hCMEC/D3 cells
in the triculture showed characteristic convex polygonal morphologies associated with
epithelial/endothelial cells. Note that several focal regions were observed while imaging the
triculture in phase contrast microscopy as well. Each focal region revealed features of either the
astrocytes, pericytes or the hCMEC/D3 cells. Thus, the formation of a triculture model of the BBB
may be monitored by a phase contrast microscope in a routine application of the method.
3.7.2 Analysis of cell-cell junctions and cell organelles
i)

Control 1 (the hCMEC/D3 monoculture)

Cell junctions between hCMEC/D3 cells in a confluent monoculture were examined by brightfield TEM microscopy. Junctions formed at the interface of two hCMEC/D3 cells varied in forms
(see Figure 3.5). Some of the cell-cell junctions between hCMEC/D3 cells formed a “key and
lock” configuration (shown by a red arrow in Figure 3.5.A) resembling the tight junctions of the
BBB endothelium illustrated in reference Figure 3.1. In other parts of the hCMEC/D3 monolayer,
there were closely overlapping cell-cell junctions (shown by a yellow arrow) showing minute
membrane connections Figure 3.5-B. Such overlapping junctions are common at the BBB
endothelium capillary [Tuma et al., 2003]. Another unique feature in the hCMEC/D3 cells was the
formation of numerous vesicles suspended in the cytoplasmic region (shown by the green arrow).
Lastly, there were numerous budding sites on the surface of hCMEC/D3 cells (shown by the blue
arrow). Such budding cell parts may be associated with the process of cell division. These features
in the hCMEC/D3 may be used to distinguish them from other cells in the triculture model of the
BBB.
ii)

Control 2 (the pericytes monoculture)

Cell features in the monoculture of pericytes were analyzed with a TEM microscope in order
to determine what characteristics that would distinguish them from other cells in the triculture
model of the BBB. While a prominent nucleus in the cytoplasm of pericytes was observed in the
TEM micrographs of pericytes, this feature was also present in the hCMEC/D3 cells, and thus
would not be used as a reliable marker characteristic of pericytes in TEM analysis. Instead, the
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paracellular gap between adjacent pericytes could be used as a distinguishing characteristic
between the hCMEC/D3 layer and the layer of pericytes in TEM micrographs.
The gaps between adjacent pericytes were expected since pericytes do not form tight junctions
at the BBB in vivo. However, in some cases, pericytes overlapped each other extensively in a close
configuration resembling that formed by the hCMEC/D3 cells. It should be noted that the overlap
among pericytes was not consistent. Instead, pericytes were more randomly oriented in space in
contrast to the more stable arrangement observed in the monoculture of hCMEC/D3 cells that were
stabilized on the surface of a filter support due to the strong tight junctions holding them together
(see Figure 3.6).
In some of the TEM micrographs, pericytes showed a large rough endoplasmic reticulum;
this could be a distinguishing feature between pericytes and astrocytes in the triculture model.
Lastly, pericytes formed numerous extracellular vesicles. Such vesicles are known to mediate the
exchange between cells [Raposo et al., 2013], consistent with the belief that pericytes play a role
in molecular trafficking with the BBB endothelium and potentially to other parts of the brain.
iii)

Control 3 (the astrocytes monoculture)

Astrocytes were examined under bright field-TEM to see if they would appear different from
pericytes and the hCMEC/D3 cells. Unlike pericytes or the hCMEC/D3 cells, astrocytes lacked
prominent cell organelles; they were more transparent to the transmission of electrons than
pericytes or the hCMEC/D3 cells. In addition, they showed varied sizes ranging from thin stellate
sections to thicker ends (see Figure 3.7). In all the cases, they seem not to form tight cell-cell
junctions like those observed in the hCMEC/D3 cells. However, in some cases they overlapped
with one another, consistent with literature that suggests the coupling behavior in astrocyte cultures
is required for the formation of gap junctions between astrocytes or between astrocytes and other
CNS-cells [Giaume et al., 1996; Nagy et al., 2000; Goldberg et al., 2010; Le et al., 2014; Hubbard
et al., 2016].
iv)

The BBB tricultures

The triculture model of the BBB was prepared by overlaying layers of astrocytes, pericytes and
the hCMEC/D3 cells on the apical side of a TranswellTM filter-support. Various thin sections of
the triculture specimen were examined to verify that cross-sectional layers of the triculture would
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contain discrete features corresponding to the hCMEC/D3 cells at the top section, pericytes in the
middle, and astrocytes in the bottom layer. Figure 3.8-A shows the formation of discrete crosssectional regions containing distinct cell features. The top section contained round and closely
arranged cells whose arrangement resemble that of hCMEC/D3 cells in a monoculture; there was
a high degree of order in the arrangement of cells at the top layer relative to the underneath layers.
The middle section of the TEM micrograph (see Figure 3.8-B) showed a disordered
arrangement of heterogeneous cells showing either features of astrocytes or pericytes. In addition,
there was a larger extracellular space that separated the bottom section of astrocytes from the
heterogeneous middle layer. The bottom layer contained cells with attributes corresponding to
those of astrocytes (see Figure 3.8-B).
The seeding protocol used in the preparation of “triculture II” (see Figure 3.9.) was optimized
by seeding well suspended cells, using a small seeding volume to allow cells to settle well on the
surface of a filter or the basal cell-cultures, and giving cells a little time to settle and attach before
transferring the culture plates into a warm sterile incubator. In addition, no collagen was applied
before seeding the hCMEC/D3 cells, so the extracellular matrix in the observed large space
between the cell layers was likely produced by the cells themselves. Astrocytes, pericytes and
endothelial cells are all capable of forming the extracellular matrix in vivo.
The purpose of developing “triculture II” was to obtain a more closely spaced stack of cell
layers that would reduce the large extracellular space observed in Figure 3.8. Thin cross-sections
of triculture II specimen revealed a minimization of the large extracellular space observed in
initially in “triculture I” where cells were not allowed time to settle on the surface of a basal
support before transferring them into the sterile incubator. In addition, characteristic cell junctions
and organelles became clearer when preparing the second set of the BBB triculture cross-sections
because a small angle of view was used to get a better focus of the tight junctions and other crosssectional features.
Several ultrastructural characteristics of endothelial cells were observed at the top layer of
the triculture. The first and more interesting feature was the formation of densely populated
vesicles in the upper layer corresponding to the hCMEC/D3 cells. Such features are associated
with endothelial cells of tumor microvessels [Skog et al., 2008]. Thus, the triculture model
developed in this study may be used as a surrogate BBB model in research programs related to
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cancer drug delivery. The second important ultrastructural feature in the top layer of the triculture
was that it contained the characteristic cell-cell junctions of a continuous endothelial layer (see
Figure 3.9-A). This is a unique property that makes the in vivo BBB more restrictive towards
paracellular permeants.
Some of the thin cross-sections in the triculture specimen showed features of astrocytes in the
middle and lower layers. Upon close inspection of Figure 3.9-A, it appeared that there were
characteristic mitochondrial structures in the stellate projections of astrocytes. The observation of
prominent mitochondria in the end-foot processes of astrocytes was expected based on the
reference micrograph of the BBB in vivo (see Figure 3.1). In addition, the localization of
mitochondria in the stellate projections of astrocytes supports previous studies showing that
astrocytes exchange mitochondria with other cells in the CNS via end-foot projections [Stephen et
al., 2014]. This high density of mitochondrial structures may be used as a distinguishing
characteristic between end-foot processes belonging to the astrocytes or pericytes. For example,
cells in the bottom layer in Figure 9-B were identified as pericytes since they lacked long stellate
projections containing any large mitochondria. Figures 9-A and 9-B showed that parts of the
triculture were layers of either astrocytes located directly underneath the hCMEC/D3 layer or
pericytes also located directly underneath the hCMEC/D3 layer.
Further analysis revealed that there were regions in the triculture that contained all the three
types of cells (astrocytes, pericytes and the hCMEC/D3 cells) directly stacked to form a trilayer in
which the hCMEC/D3 cells formed a continuous layer at the top section of the triculture. Figure
3.9-C represents regions in which a pericyte cell is sandwiched between a bottom layer of astrocyte
and a top layer of hCMEC/D3 cells. It should be noted that cells at the top layer shown in Figure
3.9-C formed a network of tightly knit cells that formed a continuous endothelial barrier. The
middle cell, a single pericyte, did not form side connections with other cells. Instead, it formed
clear physical contacts with cells underneath it or above it. Features observed in Figure 3.9
represent the kind of configuration found among the three types of BBB cells in an in vivo setting.
In summary, a triculture model of the human BBB showing a physiologically relevant
configuration was developed and characterized microscopically in a cross-sectional TEM analyses.
Current TEM micrographs revealed that the hCMEC/D3 cells in the triculture were grown to form
a continuous layer on a combined basement of astrocytes and pericytes. This is a physiologically
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representative configuration of the BBB in vivo as observed in the reference micrograph (see
Figure 3.1) where parts of the endothelium capillary are mainly covered by the astrocytes or a
combination of astrocytes and pericytes. Analyses based on cell-specific ultrastructural features
were used as a guide to identify cells in cross-sectional layers of a triculture model of the BBB. In
the future, a more accurate identification may be achieved using cell-specific immunostaining
techniques to find the relative positions of each BBB cell type in the triculture arrangement.
3.7.3 The expression pattern of F-actin in the BBB cells: astrocytes, pericytes and the
hCMEC/D3
i)

The expression pattern of F-actin in the monoculture controls

Further cell imaging assessments were conducted by determining the pattern of F-actin
microfilaments in the BBB cells through staining of the monocultures of astrocytes, pericytes and
the hCMEC/D3 cells with rhodhamine phalloidin (Figure 3.10). A fluorescent micrograph of the
astrocytes monoculture indicated that the expression of F-actin was distributed throughout their
cell body in a way that reflected their overall morphology. The expression pattern of F-actin in the
astrocytes in this study is like the pattern observed in other literature reports on the expression of
the F-actin filaments in astrocytes [Brozzi et al., 2009; Lau et al., 2011].
The distribution of F-actin in the cytoskeleton of astrocytes was different from that of pericytes
and the hCMEC/D3 cells. The F-actin filaments in pericytes were more fibrous and formed parallel
thin thread-like bundles. On the contrary, the expression pattern in the hCMEC/D3 cells seemed
to be more diffuse and gave rise to a spindle-shaped morphology of the hCMEC/D3 cells. Since
the fluorescence pattern obtained in the monoculture controls was different for each cell type, it
was hoped that each layer would be detected at distinct optical sections in a confocal microscope.
Fluorescent-sections obtained from the triculture are discussed in the next section.
ii) The expression pattern of F-actin in the optical sections of a triculture model of the
BBB:
Different optical sections of a triculture were scanned along the Z-axis using a confocal
microscope to establish if distinct fluorescent layers (or distinct fluorescent optical sections)
formed in the triculture (see Figure 3.11). While three distinct layers corresponding to the
hCMEC/D3 cells, pericytes, and the astrocytes were expected, there seem to be only two distinct
layers detected in the triculture. The first unclear layer had a fluorescent pattern resembling that of
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the hCMEC/D3 monoculture (at Z=48um) while the second one had a pattern that seem to be a
mix of two patterns corresponding to the pericytes and astrocytes (at Z=96um). Therefore, based
on the detection of two fluorescent optical sections, it was concluded that rhodhamine phalloidin
was well absorbed in the layers of the BBB triculture and could be used in future studies involving
optical sectioning of the triculture model. A more definitive immunostaining approach involving
cell-specific monoclonal antibodies for the visualization of distinct layers in the triculture, is under
development in the Knipp’s lab (Purdue University_IPPH department)

3.8

Conclusions
Various microscopic images showed that a layer of hCMEC/D3 cells cultured on a combined

basement of astrocytes and pericytes would form a physiological representation of a human BBB
in vitro. The identity of each cell layer was analyzed based on the characteristic ultrastructural
features of each cell type. Current and future studies are ongoing in the Knipp’s lab to better
delineate the localization of specific cell layers and validate the observed multicellular
configuration in the current triculture model of a human BBB.
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CHAPTER 4.
POTENTIAL APPLICATIONS OF THE BLOOD-BRAIN
BARRIER TRICULTURE MODEL AS A DRUG ABSORPTION AND
PERMEABILITY SCREENING TOOL

4.1

Summary

Background and objectives: Of critical concern to the screening of BBB permeation is
determining the in vitro model’s potential for multidrug resistant efflux-transporters to either
inhibit drug permeation or be subject to drug-drug interactions that alter neuronal exposure.
Therefore, it is necessary to determine if the models will predict potential in vivo clinical drugdrug interactions prior to advancing novel CNS-drug candidates. The present study is aimed at
comparing the effect Pgp/BCRP inhibition on the absorption of digoxin (a neurotoxic drug) using
the hCMEC/D3 monoculture or our novel direct contact triculture model. The comparison also
included a coculture of astrocytes together with pericytes since Pgp expression in the astrocytes
has been reported in numerous publications. In addition, our studies focused on developing a basic
permeability scale established using rapid and slow transcellular BBB permeants.
Methods: The mole fraction of digoxin absorbed across the aforementioned BBB cell culture
models was determined in the absence or presence of elacridar, a potent Pgp and BCRP inhibitor,
by HPLC analysis. Permeability assays were conducted using a set of radiolabeled compounds
consisting of fast BBB/brain permeants and slow BBB/brain permeants. Liquid scintillation
counting was employed to detect the rate at which molecules were ferried across the triculture
model of the BBB. A basic permeability scale was developed by defining high permeability
boundary as the position of L-histidine on the scale and low permeability boundary as the position
of verapamil.
Results: The mole fraction of digoxin absorbed in a coculture of astrocytes and pericytes was
found to be 14% in the absence of elacridar, and 20% in the presence of elacridar. For the
monoculture of hCMEC/D3, there was a 13% mole fraction absorbed in the absence of elacridar,
and a 17% mole fraction absorbed in the presence of elacridar. There was no detectable effect on
the cellular uptake of digoxin in the triculture containing both layers of astrocytes/pericytes and
the hCMEC/D3 cells when Pgp/BCRP inhibition was carried the monoculture of revealing 13%
digoxin uptake in the absence or presence of elacridar. The position of L-histidine on the
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transcellular permeability scale, developed using the direct triculture method, was at 1.2 x 10-5
cm/s, while verapamil’s position was at 1.35 x 10-6 cm/s.
Conclusions: Under similar inhibition conditions, it appeared to be more difficult to inhibit
Pgp/BCRP (transcellular barriers) in the triculture model of the BBB than in the monoculture
model. Therefore, the hCMEC/D3 monoculture model could predict different potential for drugdrug interactions from that of the triculture model. The triculture model is more in agreement with
previous studies, which showed that in vivo Pgp-inhibition might not be easily achieved by most
currently available inhibitors. Based on the preliminary triculture transcellular-permeability scale,
CNS-drug candidates would be characterized as negative BBB permeants if they show Papp < 1.35
x 10-6 cm/s and as positive BBB-permeants if their Papp ≥ 1.2 x 10-5 cm/s. However, there is still a
significant number of known CNS-positive and negative permeants that still need to be
investigated prior to establishing a more robust scale. Furthermore, in vitro in vivo permeability
correlations would be the subject of future validation studies in the laboratory.
Keywords: Blood-Brain Barrier, Efflux Transporters, Permeability Scale

4.2

Introduction
Transcellular drug transport at the Blood-Brain Barrier is regulated by different kinds of

membrane-bound transporters expressed by cells of the neurovascular BBB unit [Miller, 2015].
Membrane transporters at the BBB are classified into two broad categories; the Solute Carrier
(SLC) or the efflux (predominantly the ATP-Binding Cassette or ABC) transporters [Urquhart and
Kim, 2009]. Numerous transporters falling into each of these categories have been demonstrated
to be critical determinants of CNS-drug penetration across the BBB [Chaves et al., 2014]. The
expression of key transporters at the BBB-endothelium is highly polarized to enhance active efflux
of select molecules back into the blood stream while promoting the uptake of nutrients and other
molecules required by the neurons [Cornford and Hyman, 2005]. Therapeutic molecules
circulating in the lumen of brain capillaries may be absorbed across the BBB-endothelium by
facilitated transport or by active carrier-mediated route [Yudilevich et al., 1972].
The multidrug resistant efflux-transporters (Pgp, BCRP or MRP isoforms) clear drugs
circulating in the brain parenchyma by actively pumping them from neuronal environment across
the BBB back into the blood stream thus acting as a natural mechanism to protect the neuronal
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environment from neurotoxic compounds entering brain parenchyma by circumventing BBB
mechanisms [Kurihara et al., 1988; Loscher and Potschka, 2005]. For example, Pgp expressed in
the apical membranes of BBB-endothelial capillaries protects neurons from toxic compounds, such
digoxin [Mayer et al., 1996]. However, in the presence of a drug that potently inhibits Pgp, digoxin
may cross the BBB in high amounts to elicit neurotoxicity [Eyal et al., 2009]. Thus, drug-efflux
activities due to BBB-transporters are investigated routinely in preclinical drug screening to
minimize potentially toxic drug-drug interactions and to enhance lead candidate selection and
advancement into later clinical drug-development [Hutzler et al., 2011].
Animal BBB-cell models have been routinely utilized in preclinical studies for predicting
drug permeation and detecting potentially relevant clinical drug-drug interactions although
pharmacogenomic differences between human and animal derived cells may limit translational
efficiency [Martinez, 2011]. For a long time, the need for a proliferative, human brain microvessel
endothelial cell (BMEC) line has been recognized and then finally realized in 2005 by the
establishment of the hCMEC/D3 cells by Couraud and colleagues [Weksler et al., 2013]. The study
described in this chapter evaluates the use of a human BBB cell model (the hCMEC/D3 cell line)
for a potential application in drug-drug interactions as a triculture model.
Here we examined the effect of elacridar, a potent inhibitor of the ABC efflux transporters
Pgp and BCRP, on the cellular absorption of digoxin in the hCMEC/D3 cell monoculture, the coculture of pericytes on astrocytes and the direct-contact triculture of hCMEC/D3 layered on a coculture of pericytes and astrocytes on the filter support of TranswellTM. We hypothesized that the
effect Pgp-inhibition on the cellular absorption of digoxin would be significantly lower in the
triculture, in comparison to the effect of Pgp-inhibition on the absorption of digoxin in the
hCMEC/D3 monoculture or the co-culture of astrocytes and pericytes (separate BBB cellular
components). Note that efflux activity in the astrocyte-perictye layers of the triculture model of
the BBB may be masked by a higher efflux activity in the hCMEC/D3 cells, thus the need to
delineate the effects of each layer would be informative in establishing efflux activity in the nonendothelial cells of the BBB system.
It should be noted that some researchers grow the hCMEC/D3 cells under selective pressure
to induce Pgp function [Noack et al., 2014]. This approach may be suitable in studying how drugs
that induce Pgp function would affect the absorption and permeability of novel CNS-drug
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candidates across the direct-contact triculture model, and if the observations made would predict
similar effects in vivo. While additional primary human brain microvessel endothelial cell lines
(other than the hCMEC/D3) have been developed as novel BBB cell models, the hCMEC/D3 is
still one of the most widely utilized cell line in the BBB research and was therefore selected for
studies described in this chapter [Weksler et al., 2013].
In order to verify the expression of Pgp function at the astrocyte-pericyte sections of a BBB
triculture model, the fraction of digoxin absorbed in the presence or absence of elacridar was
conducted using the coculture to begin delineating if non-endothelial components of the BBBsystem offer addition efflux pumps that could limit permeation of Pgp substrates such as digoxin.
A significant difference in the fraction of digoxin absorbed under Pgp-inhibition would potentially
indicate the expression of efflux-system pumps in the astroglial region of the BBB, which may
further limit drug penetration even if Pgp function at the BMEC level is inhibited.
In addition, efflux activity in the astrocyte and pericyte lawn of a BBB-triculture model
would suggest the formation of a backup efflux system for reinforcing efflux activity of the
endothelial cells during normal and potentially disrupted BBB-endothelial protection for the brain.
Furthermore, astrocytes have been shown to respond to changes in the biochemical environment
of neurons by expressing Pgp [Zhang et al., 1999]. While in vitro Pgp function has been shown in
the monoculture of astrocytes, Pgp-studies involving a combination of astrocytes and pericytes in
a direct coculture setting have not been reported [Ronaldson et al., 2004]. The present study
investigates Pgp-function in a direct coculture of astrocytes and pericytes, and comparisons to the
hCMEC/D3 monoculture and direct triculture containing astrocytes, pericytes and the hCMEC/D3
cells are made to delineate separate roles of the cellular components of a human BBB.
Lastly, the potential of a direct triculture model of the BBB to rank Pgp-mediated permeability
of transcellular permeants is evaluated in this chapter. L-histidine (a non-Pgp substrate rapidly
transported into the brain parenchyma) was used as a marker for fast BBB-permeant; thiamine (a
Pgp substrate, needed by the brain cells for metabolic requirements) was used as a marker of a
rapid BBB-permeant but was expected to be slower than L-histidine. Propranolol (a lipophilic Pgpsubstrate) was expected to have slower permeability than L-histidine and thiamine. Taxol (another
lipophilic Pgp-substrate) was expected to have slower permeability than L-histidine and thiamine.
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Verapamil (a lipophilic Pgp-substrate used as a marker of very slow BBB-permeant) was expected
to be slower than all the compounds used in the transcellular permeability assays.
L-histidine is an essential amino acid required for proper functioning of the brain cells, hence
it should be readily absorbed across a physiologically relevant cell culture model of the human
BBB [Sakurai et al., 2009, Carl et al., 2010]. Thiamine is required for energy production from
glucose metabolism in the brain cells, and is transported across the BBB by a carrier-mediated
mechanism [Greenwood et al., 1982]. However, thiamine is also a substrate of efflux transporters
at the BBB, which may reduce its permeability across the BBB relative to the permeability of Lhistidine [Lockman et al., 2003].
Propranolol, paclitaxel and verapamil diffuse passively through the BBB-cell membranes,
and they may be cleared from intracellular space by efflux transporters such as Pgp [Yang et al.,
2013]. The rates of efflux clearance for propranolol, taxol and verapamil would depend on the
extent of Pgp polarization at the BBB-endothelium. If Pgp-efflux transporters were more expressed
on the luminal (blood facing apical) side, then the rates of clearance from intracellular space back
to the luminal side would be more than the rate of clearance from the intracellular space towards
abluminal (astrocyte-pericyte and neuronal basolateral) side of the BBB-endothelium. Efflux
ratios are used commonly as indicators of the effective direction for efflux activity [Thiel-Demby
VE et al., 2004].
The present study assumes that the distribution of efflux transporters is polarized towards the
luminal membranes of the cells used in seeding the BBB-triculture model, thus favoring efflux of
Pgp/BCRP substrates on the apical side of the TranswellTM filter supports used in the permeability
assays. The potential of the triculture model to rank permeability coefficients of Pgp substrates
(thiamine, propranolol, taxol, and verapamil) lower than a non-Pgp substrate (L-histidine, a
substrate for uptake transporter across the BBB) is therefore evaluated for its physiological
relevance as a tool for screening novel CNS-drug candidates in drug discovery and development
programs.
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4.3

Hypothesis

Under similar inhibitory concentration, it would be more difficult to inhibit Pgp/BCRP function in
the direct contact triculture model of the BBB in comparison to the separate endothelial or
astrocytes- pericytes constituent cell cultures.

4.4

Test parameters

4.4.1 Mole fraction absorbed
If Pgp/BCRP function is well expressed in the hCMEC/D3 cell line or the astrocytes, then the
mole fraction of digoxin (a Pgp probe molecule recommended by the FDA) absorbed when Pgp is
inhibited by elacridar (a potent inhibitor of Pgp/BCRP activity) would be greater than the mole
fraction absorbed under non-inhibitory conditions. A summary description of physico-chemical
properties of digoxin and elacridar is provided in Table 4.1. The choice of digoxin concentration
to use in the donor chamber of a TranswellTM was made in part due to the fact that it is a wellestablished and accepted molecular probe for Pgp function [Fortuna et al., 2011]. However, it is
worth noting that BCRP has overlapping substrates with Pgp that can obfuscate the interpretation
of efflux data where elacridar is a substrate for Pgp and BCRP (Bankstahl et al., 2013). Therefore,
inhibitory effects caused by elacridar would be likely due to inhibition of both BCRP and Pgp
functions in the cell cultures tested as described in the methods section.
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Table 4.1. Pgp probe substrate (digoxin) and inhibitor (elacridar)

Pgp probe (Digoxin): Aqu. Solubility = 0.127mg/mL, log P = 2.37, pKa = 7.15, and MW = 780.9 g/mol
0

"

0
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Pgp inhibitor (Elacridar): Aqu. solubility = 0.003mg/mL, log P = 6.81, pKa = 8.35, and MW = 600g/mol

I

0
0

4.4.2 Permeability of transcellular permeants
There are several transcellular permeation pathways for small molecules to traverse the
BMECs including passive diffusion, facilitated diffusion, active influx and efflux transport as
explained in Figure 4.1. The purpose of this study is not the contribution of each of these routes
in the effective permeability, but instead to evaluate how the direct-contact triculture model ranks
the expected apparent permeability values of known BBB-permeants.
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BMEC

Pericyte
Astrocyte

Neuron

Figure 4.1. Transcellular transport systems at the BBB-glial unit.
BCRP stands for Breast Cancer Resistance Protein. MRP1, -2, -3, -4
stands for Multidrug Resistance associated-Protein 1, -2, -3, -4. GLUT1
stands for Glucose Transporter 1. Pgp stand for P-glycoprotein
transporter. LAT1 stands for Large neutral-Amino Acid Transporter.
CRT1-Creatinine Transporter 1, ASCT1-neutral Amino Transporter 1,
OCTN 1, -2 stands for Organic Cation/Carnitine Transporter 1, -2 and
SNAT3 stands for Special Amino Acid Transporter 3. Note that
transport out of the brain is more favored than transport into the brain
parenchyma.

91
Table 4.2. Transcellular test-permeants

(A) Hydrophilic test-permeants
OH

l'
N
H

Urea
Solubility= 412.0 mg/mL
MW= 60.6g/mol
pKa = 0.1
BBB Transporter: UT-B
[Li et al., 2012]

Thiamine
Solubility = 1000mg /mL
MW = 265.35 g/mol
pKa =5.5
Transporter: hTHTR2
[Greenwood et al., 1982; Subramanian et
al., 2005]

L-histidine
Solubility = 62.0mg/mL
MW = 155.16g/mol
pKa = 2.6
BBB Transporter: LAT 1
[Peura et al., 2013]

(B) Lipophilic test-permeants
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0
Propranolol
Aqu. Solubility 61.7mg/mL
MW = 259g/mol
logP = 3.48
pKa = 9.42

o

o

~,

oB"

)0

Taxol
Aqu. Solubility 0.006mg/mL
MW = 259g/mol
logP = 3.0
pKa = NA
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L-histidine is known as positive BBB-permeant [Brenton and Gardiner, 1988; Yoshikawa et
al., 2014], thiamine, a hydrophilic vitamin that is transported across the BBB by an uptake
transporter even though it has been reported to be susceptible to Pgp efflux [Lockman et al., 2003].
Propranolol and paclitaxel are lipophilic substrates of Pgp used in this study as markers of slow
BBB-permeation while verapamil was used as a marker of negative permeability boundary as
following the example of Nakagawa et al., in previous studies involving indirect BBB cell culture
models [Ballatore al., 2003; Nakagawa et al., 2009]. A detailed description of the physicochemical
properties of the compounds that are considered in this study as BBB-transcellular permeants is
done in Table 4.2.
The long-term goals of this study is to establish robust permeability scales for screening
neuroactive agents or brain drug delivery systems with optimal BBB permeability. Thus, the small
set of compounds used in the current study may be further improved by incorporating more
compounds that are known to be either positive or negative BBB-permeants (following the
example of Nakagawa et al., while using a truly direct-contact triculture methodology)

4.5

Materials and Methods

4.5.1 Materials
Digoxin, elacridar, poly-L-lysine, collagen, trypsin and dimethyl sulfoxide were purchased
from Sigma-Aldrich (St. Louis, MO, USA). [3H]- propranolol and [3H]-verapamil were purchased
from Perkin Elmer (Boston MA, USA); [14C]-taxol, [14C]-L-histidine, [14C]-thiamine, and [14]urea were purchased from Moravek Biochemicals company. Hank’s Balanced Salt Solution
(HBSS), human brain astrocytes, the astrocyte media, human brain vascular pericytes and pericyte
media were supplied from ScienCell Research Laboratories (Carlsbad, CA, USA) and Dr. Pierre
Couraud of Institut Cochin (Paris, France) kindly donated the hCMEC/D3 cell line used in this
study. Endothelial Basal Medium-2 (EBM-2 media) was purchased from Lonza Group
(Walkersville, MD, USA). The 12-well format TranswellTM plates (polycarbonate inserts, 12 mm
in diameter, 0.4 um pore size) were supplied from Corning Lifesciences (Corning, NY, USA). See
Tables 4.1 and 4.2 for a detailed description of the physico-chemical properties for the tested
BBB-permeants.
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4.5.2 Enhancement of Digoxin Absorption by a Pgp/BCRP inhibitor
The mole fraction absorbed was determined in the AP coculture (A= astrocytes, P = pericytes)
the hCMEC/D3 monoculture, and the triculture. Briefly, the coculture of astrocytes and pericytes
was seeded at a density of [(4 x 104A): (4 x 104 P)] cells/cm2 and used at day 7 post pericytes
seeding. The hCMEC/D3 monoculture was seeded on a filter support of a TranswellTM as described
in section 4.4.3.1, and the triculture as described in section 4.4.3.2. For control the control studies,
cell-cultures were first incubated with a solution of digoxin (at 112 uM in 0.5% DMSO) on the
apical chamber of a TranswellTM for a period of 120 minutes. A change in the concentration of
digoxin at the end of 120 minutes was used to calculate the number of moles absorbed in the cell
layers.
To evaluate the effect of inhibiting Pgp and/or BCRP on the absorption of digoxin, solutions
containing digoxin and elacridar (112 μM and 5μM respectively, all in 0.5% DMSO) were
incubated on the apical chamber containing the cell cultures for a period of 120 minutes. The
number of digoxin moles absorbed under Pgp/BCRP inhibitory conditions was calculated from the
change in the free concentration of digoxin in the apical chamber of the TranswellTM at the end of
120 minutes. Mole fractions absorbed under AP coculture, the hCMEC/D3 monoculture, and
triculture methods were calculated using the ratio of the number of digoxin moles absorbed, to the
initial number digoxin of moles present in the apical chamber. Analytical detection of digoxin was
achieved using HPLC methods with where the mobile phase was water and acetonitrile at 70:30,
v/v, and volume of injection was 100 μL, column temperature was set at 24˚C, the flow rate was
1mL/min, and the UV-detector was set at 218 nm. Addition of 5μM of elacridar in the samples of
digoxin did not lead to analytical interference in the analysis of standard solutions of digoxin.
4.5.3 Permeability assays for transcellular permeants
4.5.3.1

Control assay in the monocultures of hCMEC/D3 cells

Immortalized hCMEC/D3 cells (frozen at passage 32) were thawed, reconstituted in the
EBM-2 media, and then passaged in vented T-75 flasks in an incubator set at 37˚C and 5% CO2.
The hCMEC/D3 cells were used after three or more passages in a T-75 flask pre-coated with
100ug/mL collagen. Confluent hCMEC/D3 cells were detached from T-75 flask using trypsin.
Trypsin was removed by centrifugation at 1500 rpm and the re-suspended hCMEC/D3 cells were
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plated in a triplicate at 8 x 104 cells/cm2 on the collagen-coated apical surface of filter inserts of a
Transwell® (0.4 μm pore size). The hCMEC/D3 monocultures on TranswellTM were placed in a
sterile incubator for 7 days, with the media was changed on them every 48hrs. The hCMEC/D3
monocultures were pre-incubated with HBSS (Hank’s Balanced Salt Solution containing 25 mM
Hepes buffer, pH ~ 7.4) for 15 minutes before carrying out transport studies.
At the start of transport studies, 1.5mL of fresh HBSS buffer was placed in the receiver
chamber and 0.5mL of fresh HBSS containing radio labelled marker compound were added at the
donor chamber. Concentrations used were 0.25uCi/mL for L-histidine, 0.25 uCi/mL for thiamine,
1uCi/mL for propranolol, 1uCi/mL for taxol and 1uCi/mL for verapamil. Samples from the
receiver chamber were collected at 15, 30, 45, 60, 90 minutes intervals during permeability assays
for paracellular permeants, and at 15, 30, 45, 60, 90, and 120 minutes during assays for
transcellular permeants (propranolol, taxol and verapamil were pre-incubated for 30 minutes
before sample collection from the receiver chamber). Transport assays were carried out on a
rocking plate at 65 rpm. Radioactivity in the donor samples was detected using a liquid scintillation
counter. Rates of mass transfer from the donor chamber to the receiver chamber were used to
calculate permeability coefficients using Equations 4.1 and 4.2 as follows:

1
𝑃𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡

=𝑃

1
𝐿𝑎𝑦𝑒𝑟𝑠

+

1
𝑃𝐹𝑖𝑙𝑡𝑒𝑟

𝑉 𝑋 𝑑𝐶

(Equation 4.1), & 𝑃𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡 = 𝑑𝑡 𝑅× 𝐴 × 𝐶𝑅

𝐷0

(Equation 4.2)

Where Papparent = Apparent permeability, PLayers = Permeability across cell layers, PFilter =
Permeability across a free filter support, VR = Volume of the receiver chamber, CR = Concentration
of the test permeant in the receiver chamber A = Area of the permeability barrier CD0 =
Concentration of the test permeant in the donor chamber at t = 0.
4.5.3.2

Assay in the triculture model of the human BBB

The direct contact, layered triculture of astrocytes, pericytes and hCMEC/D3 was carried out
on the apical surface of a Transwell filter support as described in Chapter 2. Briefly, astrocytes
were first plated at ~ 4 x 104 cells/cm2 on filter inserts that were pre-coated with 10ug/mL poly-Llysine overnight. At the end of 48hrs, astrocytes were incubated with 0.5mL of 10ug/mL poly-
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lysine on the apical side for 10 minutes at 37˚C and 5% CO2 atmosphere. Once the poly-L-lysine
solution was removed, pericytes were then plated on top of astrocyte layer at a seeding density of
~ 4 x 104 cells/cm2. At the end of 48hrs, the coculture of astrocytes and pericytes layers was rinsed
using HBSS and incubated (on the apical side) with 0.5mL, 100ug/mL of rat-tail collagen type I
for 10 minutes at 37˚C and 5% CO2. At the end of 10 minutes, the collagen solution was removed
and the hCMEC/D3 cells are plated on top of the coculture layers at a density of ~ 8 x 104 cells/cm2
to form a full triculture model of the BBB vascular unit. Permeability values were obtained as
described in subsection 4.4.3.1.
4.5.4 Statistical analysis
All experimental data were expressed as means ± SEM obtained in three or more independent
experiments. Studies were compared using unpaired one-tailed student’s t-test where two
independent means were compared, or one-way ANOVA followed by Tukey’s post hoc tests
where a control experiment was compared to two or more distinct experimental methods. A nonoverlapping 95% confidence interval (CI) was used to establish a significant difference between
two closely spaced mean values.

4.6

Results and discussion

4.6.1 Effects of elacridar on the absorption of digoxin
Efflux transporters at the BBB can affect CNS-drug disposition and pharmacodynamics
[Golden and Pollack, 2003]. The FDA recommends preclinical evaluation of new drug candidates
as potential substrates for several transporters including Pgp, BCRP, OCT2, OATP1B3, OAT1,
and OAT3 (see the FDA-Draft guidance on clinical drug interaction studies, 2017). Upon
establishing if a drug candidate is a substrate, it is recommended that prior to advancement,
potential for drug-drug interactions ought to be investigated with assays focused on Pgp, BCRP
and other multidrug resistant efflux transporters to assess the potential for clinical toxicity due to
inhibition related increases in exposure [Reynolds et al., 2011; Nix et al., 2011].
In the present study, a novel direct contact triculture model of the BBB seeded on a
TranswellTM filter support was evaluated to verify if it would lead to different Pgp/BCRP mediated
drug-drug interactions in comparison to the corresponding monoculture of hCMEC/D3 cells and
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the coculture of pericytes that were directly seeded on a lawn of astrocytes. Digoxin, an FDArecommended preclinical probe for Pgp activity, was used as Pgp/BCRP test substrate and
Elacridar, an FDA-recommended preclinical inhibitor for Pgp activity, was utilized as a test
inhibitor in the study.
While there was a noticeable efflux inhibition for digoxin in the monoculture of hCHMEC/D3
cells and in the coculture of astrocytes with pericytes, similar inhibitions of digoxin efflux were
not observed in the BBB triculture when elacridar solution was used to inhibit efflux transporters
(112μM for Digoxin & 5μM for Elacridar, see Figure 4.2). Initial results of this study suggest that
the hCMEC/D3 monoculture may predict a higher potential for Pgp/BCRP mediated drug-drug
interactions at the human BBB while the triculture model containing the hCMEC/D3 layer may
predict no Pgp/BCRP mediated drug-drug interactions between digoxin and elacridar at the human
BBB. It should be noted that an increase in the absorption/exposure of digoxin by a factor of 1.25
or greater indicates potential Pgp/BCRP mediated clinical drug-drug interactions [De la Pena et
al., 2017].
Therefore, the hCMEC/D3 monoculture model would provide different predictions on the
effect of a Pgp/BCRP inhibitor on the brain absorption of a neurotoxic compound such as digoxin.
The gain in the absorption of digoxin, upon the presence of elacridar was greater by a factor of
1.25 in contrast to the triculture model, which indicated no significant gain in the absorption of
digoxin in the presence of elacridar (Figure 4.2)
The amount of digoxin absorbed, at the end of 120 minutes, in the coculture of astrocytes and
pericytes was increased significantly when elacridar was applied onto the coculture containing
digoxin; a 20% mole fraction was absorbed when elacridar (a Pgp/BCRP inhibitor) was applied
versus 14% in the absence of elacridar. In the hCMEC/D3 monoculture, 17% of digoxin moles
were absorbed under efflux inhibition, while the extent of uptake with no-inhibition was
moderately lower at 13%. Though the percentage increase in the uptake of digoxin observed in
the hCMEC/D3 monoculture or the coculture of astrocytes with pericytes due to efflux inhibition
are minimal, they may be clinically relevant for a toxic drug like digoxin with a minimal
therapeutic window [Goldberger et al., 2012].
Contrary to the observations made under cocultured lawn of astrocytes with pericytes or the
hCMEC/D3 monoculture, there was no statistically significant increase in the absorption of
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digoxin in the direct contact triculture containing the hCMEC/D3 due to efflux inhibition with
elacridar. The mole fraction absorbed under inhibitory or non-inhibitory conditions remained the
same at 13%. The lack of increased uptake under efflux inhibition indicated that, under similar
conditions, it might be more difficult to inhibit the transcellular barrier function of Pgp and BCRP
transporters in the triculture model than in the hCMEC/D3 monoculture or in the coculture of
astrocytes layered under pericytes. Efflux action on digoxin may not be easily inhibited by using
moderate concentrations of elacridar. However, one should be careful not to use higher
concentrations of the toxic elacridar since such an approach may not be provide reliable predictions
for in vivo or clinical studies where high concentrations of elacridar would cause toxicity.
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Figure 4.2. A comparison of drug-interactions (elacridar and digoxin) in the AP-coculture versus
hCMEC/D3 monocultures, and the triculture containing hCMEC/D3 cells on a basement of
pericytes layered directly on the astrocytes. AP stands for Astrocytes Pericytes coculture. The
confidence intervals (CI) for the difference in the mean molar fraction absorbed indicated a
significant difference for values obtained under the hCMEC/D3 monoculture (n=6, at 95% CI =
0.06±0.009), and for values obtained under the AP-coculture (n=6, at 95% CI = 0.04±0.007). There
was no significant increase of digoxin absorption in the triculture when elacridar, a potent Pgp
inhibitor, was incubated in the triculture prior to the addition of digoxin (n=6, at 95% CI =
0±.0.009).
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In preclinical drug-interaction studies, the triculture would predict no potential drug-drug
interaction between elacridar and digoxin at the human BBB, while the hCMEC/D3 monoculture
would predict increased risk for Pgp/BCRP mediated drug-drug interaction at the human BBB and
hence potential neurotoxicity arising from increased levels of digoxin absorption at the BBB.
Confirmatory experiments using higher but non-toxic concentrations of elacridar are warranted to
validate whether Pgp/BCRP inhibition in the hCMEC/D3 monoculture would consistently lead to
higher absorption or permeability of digoxin in comparison to the triculture model, which currently
indicates that inhibition of Pgp/BCRP with elacridar does not lead to higher absorption of digoxin
across the human BBB. Note that observation made under the triculture model are more in
agreement with the published data showing that it is difficult to increase BBB permeation of a
Pgp/BCRP substrate in healthy human subjects by simply co-administering a potent Pgp inhibitor
such as Tariquidar [Bauer et al., 2012].
4.6.2

Permeability of hydrophilic transcellular permeants

The BBB acts as a nutritional conduit for delivering hydrophilic nutrients such as amino acids
and vitamins from blood in circulation, and may be involved in clearing hydrophilic metabolic
products such as urea, and carbon dioxide [Friss et al., 1980; Doran et al., 2006; Marchi et al.,
2016]. A comparison of permeability coefficients for urea, L-histidine, and thiamine was expected
to show a higher permeability for L-histidine and urea when compared to thiamine, which may be
susceptible to efflux transport at the BBB [Lockman et al., 2003]. In addition, it was expected that
the transcellular permeation rates of hydrophilic urea, histidine, and thiamine in the monoculture
of hCMEC/D3 cells would be different in comparison to the triculture. As expected, the
permeability of urea was greater than that of thiamine (1.6 x greater than the permeability of
thiamine across the hCMEC/D3 monoculture, and 1.7 x greater than permeability of thiamine
across the triculture; see Figure 4.3).
The permeability of L-histidine, a substrate for uptake transporters at the BBB, was greater than
that of thiamine under the mono- and –triculture models. L-histidine permeability was 1.9 x greater
than thiamine permeability under the hCMEC/D3 monoculture and 1.6 x greater under the
triculture. The lower permeability of thiamine may be attributed to its interaction with efflux
transporters as previously reported in animal studies (Lockman et al., 2003) but additional
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confirmatory studies are needed to validate this observation at various concentrations and efflux
inhibition preferably using a human cell line with higher Pgp expression.
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Figure 4.3. A comparison of hydrophilic transcellular permeability coefficients across
mono- and tri-culture models. There was no significant difference in the permeability
of hydrophilic transcellular permeants across mono- and tri-culture models of the
human BBB. Urea seem to have a higher permeability across the triculture than across
the monoculture (the 95% CI = 0.15±0.073). On the contrary L-histidine exhibited a
lower permeability in the triculture (the 95% CI = 0.36±0.121). Thiamine showed
similar permeability across the mono- and triculture models of the BBB in this study
with a 95% CI of (0.03±0.094)

A hypothetical permeability data set would include positive hydrophilic BBB-permeants such
as guanidine compounds and essential amino acids (leucine, valine tyrosine, tryptophan,
phenylalanine, and isoleucine) and a negative data set corresponding to poor BBB-permeants such
as glutamate, norepinephrine, and the catecholamines dopamine [Bothe et al., 2014; Kostrzewa,
2007]. A resulting permeability scale might be used in defining boundaries between BBBpositive/negative permeants in the triculture model. Ultimately, a better-defined permeability scale
could be useful in deciding whether novel CNS-drugs, prodrugs, or nutrients might have the
required permeability at the BBB in vivo.
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4.6.3 Permeability of lipophilic transcellular permeants
The BBB is implicated in a selective passive transcellular (lipophilic) permeation, allowing
certain lipophilic molecules such as propranolol or diazepam to diffuse through its cell membranes
more easily than certain others such as verapamil or chloroquine [Eigenmann et al., 2016]. Various
physicochemical factors such as molecular size, shape, weight and solvent accessible surface areas
influence BBB selectivity for transcellular diffusion of molecules into the brain parenchyma
[Ghose et al., 2012; Geldenhuys et al., 2015]. Though consideration of optimal physicochemical
properties is crucial in CNS drug design, predictions based on physicochemical properties often
have to be verified in cell-based assays or animal models for BBB-permeability [Rankovic, 2015].
The present study aimed at establishing if the proposed triculture model of a human BBBB would
rank the permeability of an initial small set of transcellular permeants in a reasonable order based
on the published literature.
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Figure 4.4. A comparison of lipophilic permeability coefficients for propranolol and
verapamil. There was no significant difference in the permeability of lipophilic
transcellular permeants (propranolol and verapamil) under the mono- and tri-culture
models. The 95% CI for the difference in the mean P app values were 1.16±1.734 for
propranolol and 0.05±0.802 for verapamil. However, the permeability value of
verapamil, a Pgp-marker compound, was significantly lower than that of propranolol,
a marker of fast transcellular permeation, both in the mono- and triculture settings (the
95% CI intervals for the differences in the mean Papp values were 3.52±1.792 under
the monoculture settings, and 2.41±0.634 under the triculture settings.
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For example, propranolol a lipophilic positive BBB-permeant was expected to exhibit higher
permeability than verapamil, another lipophilic agent that is a potent substrate of efflux
transporters including Pgp and BCRP which restrict its permeability across the BBB much more
than propranolol (see Table 4.2 for details on physicochemical properties).

Under the

hCMEC/D3 monoculture model, the permeability of verapamil was 3.6 x lower than permeability
of propranolol. However, in the triculture model, the permeability of verapamil was 2.8 x lower.
This indicates that the monoculture shows a better permeability resolution between fast and slow
transcellular permeants; however, more permeability assays are required to verify this observation
(see Figure 4.4. for details).
A transcellular permeability scale based on the proposed triculture model should be developed
for a wider industrial application in studies related to brain drug delivery across a human BBB.
For example, the permeability of propranolol may be used to set a permeability boundary that
defines moderate BBB-permeants, while verapamil may be used to set a boundary for negative
BBB-permeants as exemplified by a commercial permeability scale used at Alpha Bioregen [Alpha
Bioregen webpage, accessed on June 2017]. Similarly, the permeability of verapamil could be used
to define a lower permeability boundary for impermeable compounds.
4.6.4 A basic permeability ranking scale for transcellular permeants
A transcellular permeability scale containing both hydrophilic and lipophilic compounds with
reference positions defining high and low permeability points may better reflect a selective
transport property in the direct contact triculture model of the BBB proposed in this thesis. The
high transcellular permeability positions on the scale could be defined by essential nutrients known
to cross the BBB rapidly to meet nutritional demands for neurons in the brain parenchyma. Certain
neutral amino acids such as L-tyrosine, L-phenylalanine, L-leucine, and L-histidine get absorbed
into the brain parenchyma via carrier-mediated transporters across the BBB into neuronal
environment in order to fulfill nutritional and metabolic requirements [Yudilevic et al., 1972].
Therefore, L-histidine was selected to be used in defining a high permeability threshold based on
the triculture model. Similarly, Thiamine was selected as an essential vitamin needed for proper
functioning of the brain cells and hence was expected to show either moderate or high permeability
values relative to the permeability of propranolol, paclitaxel or verapamil, lipophilic molecules
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that may cause brain neurotoxicity [Harata et al., 1995; Olesen et al., 1978; Fellner et al., 2002;
Fang et al., 2013].
Therefore, propranolol, paclitaxel and verapamil were selected to define moderate to low
permeability positions on the permeability scale for transcellular permeants across the proposed
triculture model. These three compounds are known to be substrates of Pgp and hence were
expected to show lower permeability values in comparison to L-histidine and thiamine that should
enter the brain via BBB to fulfill certain nutritional demands by the brain neurons [Pires et al.,
2008; CEREP application notes, 2013]. Note that, a more robust scale would require additional
compounds to define extremely low permeability positions. Compounds such as digoxin,
tariquidar and elacridar may be employed to establish low permeability positions on the
permeability scales [Alphabioregen application notes, 2017].
Therefore, the small data set illustrated in Figure 4.5 was used to provide a “Proof of
Concept” for advancing the triculture methodology as a physiologically relevant approach for
ranking permeability coefficients of novel CNS-drugs/drug delivery systems. Note that, the
hCMEC/D3 cell line is not stably transfected with a Pgp plasmid; thus a human BBB cell line
showing higher expression of Pgp will be required for use in the development of a more robust
permeability scale for commercial applications.
Based on initial data, permeability of L-histidine was 14x higher than that of verapamil, but
only 5x higher than that of paclitaxel or propranolol, which are moderate Pgp substrates. Similarly,
the permeability of thiamine was 9x higher than that of verapamil, and only 3x higher than that of
paclitaxel and propranolol. It is speculated that the higher permeability of L-histidine may be due
to lack of interaction with efflux pumps such as Pgp and BCRP and a rapid transport by the uptake
transporters such as LAT1 and other amino acid transporters expressed in the hCMEC/D3 cells.
The permeability boundaries defined by the current compounds indicate that low-permeability
compounds would have an apparent permeability coefficient in the neighborhood of 1.35 x 10-6
cm/s (i.e., verapamil’s placement on the scale). Intermediate-permeability compounds would show
values around 3.8 x 10-6 cm/s (i.e., propranolol’s position), and high-permeability compounds
would show 1.2 x 10-5 cm/s or higher (thiamine and L-histidine’s position).
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Figure 4.5. A basic permeability scale for a small set of transcellular BBB-permeants. Blue and Green
compounds represent high BBB permeant-markers, yellow compounds are indicative intermediate permeability
markers, and the red compound indicates lower permeability. The triculture model is capable of ranking
different permeants in different permeability categories (a one-way ANOVA test indicated the difference where
n = 3 in each category, with a p-value < 0.001). A post hoc Tukey’s Honestly Significant Difference value of
0.036 indicated that propranolol and paclitaxel had similar apparent permeability values with a non-significant
difference (HSD > 0.009) in the mean values.

Note that this is a dynamic scale and the boundary positions may be defined differently as new
compounds are screened and new permeability rankings become well established on the scale.

4.7

Conclusions
One of the main objectives in this study was to compare the effect of inhibiting Pgp in a direct

coculture of astrocytes and pericytes that mimics a component of the BBB system, then the
hCMEC/D3 monoculture that partially mimics the BBB system and finally a triculture model. The
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direct contact triculture model mimicked a full BBB system, containing three principal cellular
components (the hCMEC/D3 seeded directly onto a lawn co-culture of pericytes on astrocytes).
Under similar inhibitory concentrations, there was more absorption of digoxin molecules in the
coculture of astrocytes and pericytes as well as in the monoculture of hCMEC/D3 cells than in the
triculture model. These initial results therefore indicate that the proposed direct-contact triculture
model may predict different potential for Pgp/BCRP mediated drug-drug interactions at the human
BBB. It is worth noting that the proposed direct-contact triculture model showed that Pgp/BCRP
did not lead to a highly significant increase in the absorption of digoxin (a Pgp substrate). This
observation is in agreement with other reports in the literature showing that only minimal increases
in brain exposure of a Pgp drug substrate is achieved in healthy human subjects upon coadministration with a potent Pgp inhibitor.
Another aim of the study was to develop an initial transcellular permeability scale in order to
define high and low permeability thresholds. Under current scale, a permeability position between
positions of propranolol and L-histidine permeability coefficients would be defined as high.
However, a permeability position between propranolol and verapamil positions would be defined
as intermediate, while below verapamil position would be defined as a negative permeability value.
The author’s opinion in this thesis is that a novel CNS compound showing a permeability value
similar or less to that of verapamil would be less likely to permeate through the human BBB in
vivo. Certainly, further validation work is still needed before adopting the triculture model as a
screening tool in research programs related to CNS-drug discovery and development.
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CHAPTE RS.
DISSERTATION HIGHLIGHTS AND LONG-TERM
PERSPECTIVES ON THE DEVELOPMENT OF LAYERED CELL
CULTURE MODELS OF THE HUMAN BLOOD-BRAIN BARRIER

5.1

Dissertation highlights
A major goal of this thesis was to develop a direct-contact triculture model for mimicking the

BBB-physiology in vitro. A mini-review on the BBB-physiology and transport functions was
written in chapter one to justify why a direct layer-by-layer methodology for the preparation of a
BBB-model on a Transwell™ would lead to a more physiologically representative configuration
of the BBB in vitro. The relevance of optimal direct-contacts (e.g., gap and peg-socket junctions)
in molecular exchange/signaling between the BBB cells was highlighted. The direct-contact
triculture methodology and its variant approaches in a Transwell™ chamber were proposed to
allow for the development of a more physiologically relevant cell culture model of the BBB with
a cellular arrangement and interactions resembling those of the BBB in an in vivo setting.
Initial development and characterization of a direct-contact triculture method for mimicking
the BBB in vitro was described in Chapter II. Initial studies described in Chapter II indicated that
a layer-by-layer coculture of astrocytes and pericytes form a resistant paracellular barrier to the
flux of mannitol with a similar magnitude to that measured in the monoculture of hCMEC/D3 cells.
Thus, the popular view that astrocytes and pericytes influence the BBB-functions only through
inductive effects may not be completely accurate. Based on our initial data, astrocytes together
with pericytes may be important direct contributors in restricting permeation in an additive or
potentially synergistic fashion across the BBB system contrary to the contemporary notion that
non-endothelial BBB cells do not form a distinct physiological barrier to the absorption of small
or large molecules across the BBB.
Although both astrocytes and pericytes showed similar effect on reducing the paracellular
permeation when directly co-cultured in layers with the hCMEC/D3 cells, the observed reduction
in the effective permeability of a small paracellular permeant such as sucrose was not additive in
the triculture where both astrocytes and pericytes were present. It seemed as if there was a limited
extent by which the permeability of small paracellular markers due to the inclusion of the
astrocytes or pericytes in the triculture model. Further mechanistic studies on the role of
interactions between cells found in the neurovascular unit on the effective permeation of small or
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large hydrophilic molecules across the BBB in vitro, may assist in delineating the extent by which
astrocytes and pericytes influence paracellular permeation routes across the BBB system.
Nevertheless, it was noted that a direct-contact triculture model of the BBB, containing a
combined basement of astrocytes and pericytes, and a continuous top layer of hCMEC/D3 cells
was consistently more restrictive than the corresponding monoculture of hCMEC/D3 cells based
on the results from permeability assays using the established small and large hydrophilic
paracellular permeants. Therefore, the proposed triculture model better mimicked the paracellular
tightness associated with the BBB physiology in vivo.
While Chapter II dealt with establishing a stable triculture model of the human BBB on a
Transwell™, Chapter III described imaging of ultrastructural features in the cultures of BBB cells
used in the preparation of the triculture model. Monocultures of separate BBB cells (astrocytes,
pericytes and hCMEC/D3 cells) were used as controls to identify distinct ultrastructural
characteristics in the layers corresponding to the astrocytes, pericytes or the hCMEC/D3 cells in
the triculture model of the BBB containing all the these cells on a TranswellTM support. The
observed ultrastructural features in the cross-sectional specimens of a BBB-triculture were finally
compared to the ultrastructural features published in a reference micrograph of a human BBB by
Farkas et al., 2001.
A major objective in Chapter III was to establish the unique physical and morphological
features corresponding to the layers of hCMEC/D3 cells (a transformed primary human brain
microvessel endothelial cell model), human brain vascular pericytes, and human brain astrocytes.
The hCMEC/D3 layer was continuous due to the formation of tight cell-cell junctions between
adjacent hCMEC/D3 cells. The hCMEC/D3 layer contained several vesicles spanning across cell
membranes indicating that transcytosis may be a contributing transport process occurring within
the hCMEC/D3 cell layer. There is a wide scientific interest in using vesicular transcytosis for
CNS-drug delivery across the BBB [Lajoie et al., 2015; Mäger et al., 2016]; the proposed triculture
model may find useful applications in preclinical evaluation of receptor mediated drug delivery
strategies for treating neurological diseases.
To the contrary, monolayers of pericytes or astrocytes lacked a consistent formation of tight
cell-cell junctions, based on the analysis of TEM micrographs, and hence could not form
continuous cell layers. More specifically, numerous gaps were observed at the cell-cell junctions
in the monocultures of astrocytes and pericytes, suggesting that astrocytes or pericytes, on their
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own, may not form an effective paracellular barrier to the flux of hydrophilic molecules. Since
both astrocyte and pericyte densities may vary regionally along the brain endothelial capillaries/the
neurovascular system, it is not clear if the seeding densities examined in the current studies would
be representative of the coverage densities along the cerebral endothelial capillary system. The
extent by which astrocytes and pericytes cover brain capillaries may determine the BBB
physiology and functions [Watkins et al., 2014]. Therefore, more astroglial and pericytes seeding
density ratios may have to be explored in the future, to understand how seeding density ratios
would affect the formation of cell-cell junctions of among astrocytes or pericytes and to delineate
how changes in the astrocytes or pericytes coverage of the BBB capillary would influence its
functions.
The layered, direct-triculture model in which astrocytes and pericytes provided a
physiologically relevant basement on which the hCMEC/D3 cells grew to form a continuous layer
showing tight cell-cell junctions in TEM analyses. The cross-sectional TEM analyses of the
triculture specimen showed that a consistent layer of hCMEC/D3 cells was formed at the top
section, while the bottom layer contained areas of astrocytes or astrocytes mixed with pericytes.
Thus, the cross-sectional configuration of the triculture model resembled the cross-sectional
configuration of the BBB-glial vascular unit in vivo, where either the astrocytes or pericytes or
both cell types cover brain capillaries.
After establishing the similarity in physiological configuration between the BBB-triculture
model and the BBB in vivo by TEM analyses, the next objective was to evaluate the potential
application of the triculture model in drug transport assays. A select set of model compounds was
used to test the permeability rank order expected in a functional triculture model of the BBB; this
set of compounds contained molecules expected to use different pathways of permeation including
nutrient-carriers (facilitated diffusion), passive transcellular permeation, and efflux mediated
transport. The main goal was to evaluate the potential of a direct-contact triculture model of the
BBB to classify the permeability of established BBB permeants into fast or slow categories, and
to validate the observed rank order using published literature on the permeability of the testpermeants across the BBB.
L-histidine and thiamine, essential brain nutrients, were expected to traverse the BBBtriculture model more quickly than propranolol, paclitaxel (a Pgp substrate), and verapamil (a
substrate of efflux transporters such as Pgp and BCRP) that represent typical neurotoxic drugs that
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would be found in blood circulation of cardiac or cancer patients. Recognizing that propranolol (a
substrate of Pgp), paclitaxel (a Pgp substrate) and verapamil (a Pgp substrate) are known substrates
of efflux transporters, they were expected to be much slower in traversing the BBB-triculture in
comparison to L-histidine or thiamine. There, the permeability ranking function for these testpermeants was examined in the triculture model to establish its potential application as a
permeability screening tool of novel CNS-drugs or CNS-drug delivery technologies.
The direct-contact triculture model revealed its potential for ranking the expected permeability
order from high permeability of L-histidine and thiamine, to moderate permeability values for
propranolol and paclitaxel, and to low permeability of verapamil which is an established marker
for low permeability across the BBB models. Thus, the triculture exhibited a good potential for
application in ranking molecular permeability coefficients based on a small set of test permeants
in the present study. Additionally, the effects of Pgp inhibition on the absorption of a typical Pgp
substrate (digoxin) were analyzed and compared between the hCMEC/D3 monoculture, the
coculture of astrocytes and pericytes, and the triculture which is a full representation of the BBB
cellular composition. Elacridar, a non-competitive Pgp inhibitor, was used to make comparisons
of the Pgp function in the fore mention cell cultures that offer partial or full representation of the
BBB configuration in vitro.
Initial results indicated that it is relatively more difficult to inhibit Pgp/efflux function in the
triculture model of the BBB than the hCMEC/D3 monoculture model, which is a partial
representation of the BBB in vitro. This observation further supports the relevance of a triculture
methodology in mimicking the BBB in vitro as it is more in agreement with previous in vivo studies
showing that inhibition of Pgp at a healthy BBB did not lead to higher absorption of drugs in the
brain. However, additional studies using alternative BBB cell lines should be investigated to
determine if high Pgp expressing cells would provide a better comparison to the in vivo BBB
function.

5.2

Long-term strategies for advancing the triculture-methodology
Numerous approaches have been proposed, in various literature on the BBB, on how to improve

tightness in the BBB cell-culture models. In one of the most recent publication, Katt et al. reported
using retinoic acid to modulate the expression of important tight junctions and efflux transporters
[Katt et al., 2016]. The use of retinoic acid led to high TEER values in the hCMEC/D3 cell line (a
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BBB-cell model) from low values of around 50 Ω-cm2 to high values of around 2000 Ω-cm2. In a
different approach, the hCMEC/D3 cell-layer grown under flow-dynamic conditions demonstrated
a 20-fold increase in TEER values relative to the hCMEC/D3 cells grown on a Transwell™
chamber under minimal shaking conditions [Cucullo et al., 2007].
Therefore, the issue in the BBB cell culture models may no longer be how to tighten the
paracellular pathway, but rather how to mimic the BBB in vitro in a configuration that resembles
that of the BBB as observed in an in vivo setting. A physiologically relevant model ought to mimic
the diffusional paths that a novel CNS-drug or drug delivery system would traverse across the
BBB to get to the brain parenchyma. The direct contact triculture model invented in this research
represents the initial step towards providing true physiological relevancy for enhanced prediction
of novel molecules with optimal BBB permeation properties or drug delivery technologies with
enhanced capability for permeating through a neuro-defensive BBB system. Suggestions on how
to implement the triculture methodology in an industrial setting where high throughput screening
technologies may be available are discussed next.
5.2.1 High throughput implementation of the triculture methodology
The Blood-CNS interfaces, including the BBB, act as neuroprotective barrier that control
molecular trafficking between the CNS and peripheral systems [Bauer et al., 2014]. The BBB
achieves its selective restrictive properties through a complicated network of protein-protein
interactions in the cell-cell junctions of the BBB endothelial capillaries and biochemical signals
transmitted through non-endothelial cellular components of the neurovascular unit [Alvarez et al
2011; Tietz and Engelhardt 2015]. Thus, the effect of exogenous chemical agents on the
normal/abnormal functions of the neurovascular unit would be a subject of interest in CNS-drug
discovery and delivery programs where effects of novel CNS-drug candidates and CNS-drug
delivery technologies on the BBB physiology or functions may have to be established before
realizing a successful clinical outcome. Failure to follow this approach may result in deleterious
neurotoxicity or a lack of clinical efficacy in the later stages of drug development.
The chemical space of interest in general drug discovery programs is of astronomical order
(1020 – 1024 molecules of interest to medicinal chemists) [Reymond et al 2012; Reymond et al
2015]. Therefore, a high throughput screening approach is traditionally employed to discover
molecules with therapeutic actions on biological targets of interest by screening several thousands
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of molecules. For example, 10,000 molecules per day in high throughput screening or 100,000
molecules may be evaluated per day in ultra-high throughput screening with the goal of increasing
the probability of getting a hit molecule from such a large chemical space [Szymański et al 2012].
Efforts to discover molecular chemotypes that have interesting chemical action on the
neuroprotective functions of the BBB may involve large sets of compounds (0.5 to 2.8 million, a
typical library of compounds for a big pharmaceutical company like Pfizer) [Hansen et al., 2016].
Implementation of the direct triculture methodology within HTS technologies in drug discovery
and early development programs may provide better prediction of in vivo performance than the
conventional indirect triculture techniques.
Probing drug actions on a triculture model of the BBB in a high throughput-screening manner
would require fast and well-designed assays. A direct layering of BBB cells on the apical surface
of a TranswellTM chamber to create a direct-contact triculture model for mimicking the BBB may
be more amenable in high throughput screening technologies. It would be faster and easier to
automate direct seeding of BBB cells on the apical surface of a TranswellTM in comparison to
indirect methodologies, where manual seeding may be required to plate cells on different sides of
a Transwell™ filter support.
Application of the triculture methodology in probing chemical effects on the normal (or
abnormal) BBB-signaling functions may require a unique triculture configuration depending on
the analytical method used. For example, if a high content imaging detection is required on the
neurons cultured in a BBB-environment, it may be suitable to design automated experiments in
which BMECs would be plated on the apical surface of a Transwell™ first, pericytes second,
astrocytes third, and neurons of interest (diseased or normal) fourth to form a multilayered
configuration in vitro.
Once the resulting neuronal-BBB culture is stable, it may be transferred to a well containing
a compound of interest in the basolateral chamber to evaluate its BBB-permeability and neuronal
effects, all in a single assay. Thus, a library of compounds may be screened in phenotypic assays
and correlation models relating physical-chemical properties and neuronal effects might be
obtained using a triculture model of the BBB in a neurological environment.
Implementation of the triculture methodology in a high throughput screening assays would
need to fulfill many more requirements. These may include a well-designed automation scheme,
well-validated assays to reduce the number of false negatives or positives, digital capability to
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collect, store, and analyze large data sets, and finally a lot of time since high throughput screening
projects may take months or years before obtaining useful data sets for applications in modeling
[Macarron and Hertzberg, 2009]. The time and resources in high throughput screening projects
may also vary depending on the purpose; CNS-drug formulation studies or drug delivery projects
may require less time in comparison to the BBB-target identification and validation projects.
5.2.2 Inclusion of brain neurons in the direct-contact triculture model of the blood-brain
barrier
The current opinion from BBB-experts is that the main problem with neuronal drug delivery
is how to deliver a neurotherapeutic drug candidate across the BBB-unit in a sufficient amount to
elicit a desired pharmacological effect [Banks, 2016; Pardridge 2016]. Thus, a BBB cell culture
model in a TranswellTM that truly mimics all the cellular barriers that a drug molecule destined to
a diseased neuron in the brain parenchyma would encounter, may be more useful than a model that
partially represent its diffusional path towards neurons in the brain parenchyma.
Prediction of a free fraction of a drug that escapes BBB protective mechanisms to gain access
to the brain parenchyma and its neurological effects are the most important goals in the successful
application of the in vitro triculture model of a human BBB described in the preceding chapters.
Inclusion of an additional direct layer of neurons in the model may render it to be more robust in
the prediction of the free fraction of a drug that would be bioavailable to neurons in the brain
parenchyma. In addition, other pharmacological parameters of interest may be better predicted
when the BBB is mimicked in neurological environment as depicted in Figure 5.1.
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Figure 5.1. Conceptual designs on how to mimic a preclinical BBB-glial unit system
in a neuronal environment. Panel (A) shows a direct-contact model of the BBB in a
neuronal environment on the apical chamber of a TranswellTM. Panel (B) illustrates a
direct-contact model maintained in a neuronal environment on the basolateral chamber
of a TranswellTM.

5.2.3 Development of In Vitro In Vivo correlation models, refinements and
commercialization
The ability to predict neuronal drug exposure using in vitro techniques is highly complex and
may not be achievable in a short period. However, if in vitro data on the permeability of drugs
across a triculture model of the human BBB including the free fraction of drugs that escape BBB
protective mechanisms, and data on the required concentration of drugs for causing desirable
neurological effects are available, then robust predictions regarding in vivo brain pharmacokinetics
and pharmacodynamics may be attained from in vitro studies that mimic well the BBB physiology
and function.
In this endeavor, the Positron Emission Technology (PET available at Purdue University) may
be useful in providing in vivo data sets regarding brain pharmacokinetic parameters that would be
used in the development of IVIVC models for routine applications in CNS drug research and
development programs. While IVIVC studies in brain drug disposition may require a large
collaboration between various groups, the BBB cell culture models may be used to collect in vitro
transport parameters. Examples of relevant pharmacokinetic parameters would include the free
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fraction of drug available to the neurons-Fa, the apparent permeability-Papp, transporter kinetic
parameters-Km, and Vmax, or the link between in vitro transport parameters and in vitro neuronal
phenotypes of interest to medicinal chemists. Such in vitro pharmacokinetic and
pharmacodynamic data sets could then be correlated with in vivo data sets collected or published
from other BBB researchers from around the world.
Ultimately, the 3D-cell culture models conceived in this study may be commercialized to
companies in the business of neurological drug discovery and development. Companies like
Neuromics (Edina, Maine, USA) or Alphabioregen (Boston, Massachusetts, USA) may be
interested in a 3D-model of the BBB cultured in a neuronal environment to allow for coupling of
drug permeability and phenotypic assays in one BBB-kit.

Figure 5.2. A framework for the application of BBB cell culture methods in the
development of IVIVC models. The ultimate goal is to generate robust IVIVC
models capable of predicting pre-clinical or clinical pharmacokinetic and
pharmacodynamic parameters of interest in CNS-drug development. For example,
data sets from pre-clinical models such as a mouse could be used to assist in the
development of IVIVC models for predicting drugs/drug delivery systems that
would lead to optimal drug exposure to the brain parenchyma. IVIVC models may
be continually refined as more data from in vivo and in vitro studies become
available from various researchers.

Therefore, one of the most important steps in the final development of the layered 3D-BBB
cell culture models would be to establish a reliable preservation technique that would allow one to
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sell precultured BBB models to companies involved in the development of neurological drug
delivery technologies. Initially it would be beneficial to develop the direct contact 3D-BBB kits
and test if they can be preserved at -80˚C and if they can be thawed to recover the original BBBdrug transport properties in a few days (~7 days), as done in the current 3D-BBB kits at Neuromics.
To summarize, a 3D-human BBB cell culture model showing robust disease specific IVIVC
models and potential for development into a commercial kit would bring good financial returns
from the time and money invested in its conception and development.
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APPENDIX A. SUPPLEMENTAL DATA ON THE BASAL CULTURE OF
ASTROCYTES AND PERICYTES

Supplemental Figure 1. Pericytes cultured alone on the surface of a
TranswellTM filter support. Pericytes did not grow to cover the surface
completely even at the end of day 7. The bar represents 100 μm
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Supplemental Figure 2. Pericytes grown on a basal culture of astrocytes
multiplied to cover the underneath astrocytes completely at the end of day
7. The bar represents 100μm

Supplemental Figure 3. Astrocytes cultured on a basal layer of
pericytes for 7 days. Astrocytes on the top layer multiplied to cover most
of the underneath pericytes. The characteristic needle-like projections,
which are unique features to the astrocytes, were clearly visible on the
astrocytes. The bar scale represents 100 μm
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APPENDIX B. SUPPLEMENTAL TEM MICROGRAPHS OF THE BBB
TRICULTURE

L1

L2
L3

L1
L2

Supplemental Figure 4. Thin cross-sectional TEM
micrographs of a BBB triculture. Panel A shows a section
where three layers (L1, L2, and L3 formed). Panel B shows
a section where two cell layers are formed (L1, and L2). It
is hoped that a non-ambiguous identification of the cell
layers of the BBB triculture will be made using cellspecific staining antibodies as a continuation of the
research presented in the current dissertation. The bar scale
represents 0.5 μm

